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1. Abstract 
Heart transplantation (HTx) not only reduces mortality of patients with end-stage heart 
failure (HF), but also improves the quality of life of these patients. However, heart 
transplant recipients (HTRs) experience a decrease in exercise capacity, which is 
associated with increased mortality of cardiovascular patients. This literature review 
provides not only the basic clinical application of HTx, such as recipient selection and 
surgical techniques, but also unique physiological abnormalities after surgery. Factors 
that are related to chronotropic incompetence, side effects of immunosuppressant 
medications, and deconditioning result in decreased exercise performance in HTRs. 
The benefits of exercise-based cardiac rehabilitation (CR) are outlined in this literature 
review. Exercise training (ET), which consists of aerobic, resistance and flexibility 
exercises, is effective in improving peak oxygen consumption ( VO2peak) and skeletal 
muscle performance in HTRs. There is evidence that the use of high-intensity interval 
training (HIIT) can improve chronotropic responses to exercise and reduce the 
progression of cardiac allograft vasculopathy (CAV), which limits long-term survival 
rates in HTRs. Finally, it should be noted that the normal ageing process may affect 
long-term outcomes of ET in HTRs. 
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2. Introduction 
HTx is recommended as the gold standard treatment for selected people with 
refractory end-stage HF (Yancy et al., 2013). After surgery, patients undergoing HTx 
have improved health-related quality of life (HRQoL) (Grady et al., 2007; Grady, 
Jalowiec, & White-Williams, 1996; Mantovani et al., 2016). HTx has also been widely 
accepted as a life-prolonging treatment (Schroeder, Moffatt, Berry & Robbins, 2004) 
and it can effectively decrease mortality of high-risk patients with advanced HF (Deng, 
De Meester, Smits, Heinecke, & Scheld, 2000). Since the only 18-day survival of the 
first human HTx in 1967 (Brink & Hassoulas, 2009), currently, the median survival 
period of adult HTRs is 10.7 years, according to the International Society for Heart and 
Lung Transplantation (ISHLT) Registry data (Lund et al., 2017). 
Although post-transplant survival has increased due to advances in HTx procedures, 
including surgical techniques, criteria for HTx candidates, and immunosuppressive 
medications to control allograft rejection (Lund et al., 2017), exercise capacity and 
HRQoL of HTRs remain lower than their normal counterparts (Anderson et al., 2017). 
A unique physiology due to complete denervation of the transplanted heart (Hunt, 
1998) is associated with exercise intolerance in HTRs (Keteyian, 2013; Silva & Cipriano, 
2016). Moreover, negative side effects of lifetime immunosuppressive drug therapy 
not only cause infections, which are the leading cause of death in the first year after 
HTx (Colvin et al., 2018; Lund et al., 2017), but are also the possible causes of CAV 
(Keteyian, 2013; Silva & Cipriano, 2016), which remains a crucial problem that limits 
long-term survival rates in HTRs (Colvin et al., 2018; Hunt, 1998; Lund et al., 2017). 
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CR has been shown to reduce morbidity, mortality, hospital admissions, and to 
improve quality of life (QOL) as well as psychological well-being in individuals 
diagnosed with cardiovascular disease (Dalal, Doherty, & Taylor, 2015). The British 
Association for Cardiovascular Prevention and Rehabilitation states that HTRs also 
benefit from CR (BACPR, 2017). Early provision of CR or secondary prevention 
programmes to all HTRs has been recommended in international guidelines (Thomas et 
al., 2010). However, many guidelines for HTRs mainly focus on exercise rehabilitation 
(American Association of Cardiovascular and Pulmonary Rehabilitation [AACVPR], 
2013; American College of Sports Medicine [ACSM], 2018) because improving exercise 
capacity has been highlighted as an important goal to prolong the life of the individual 
(Silva & Cipriano, 2016) due to a decrease in mortality rates, as reported by Myers et 
al., (2002). 
This review provides the basic clinical application of HTx, including patient selection, 
surgical techniques and immunosuppressant therapy, physiological changes, 
complications and exercise performance after HTx, and exercise-based CR for HTRs and 
its benefit. 
3. Heart transplantation 
3.1 Recipient selection 
Although HTx is known as an effective treatment for individuals with end-stage HF with 
reduced ejection fraction (Katz, Waters, Hollis, & Chang, 2015), this procedure is 
recommended for eligible patients who meet the criteria as outlined in Table 1 (De 
Jonge et al., 2008; Deng, 2002; Dennell, 2009; Hunt & Frazier, 1998; Isaac et al., 2011; 
Katz et al., 2015; Mehra et al., 2006). 
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Table 1 Indications (A.) and contraindications (B.) for heart transplant candidates 
A. Indications 
• End-stage heart failure 
• Refractory life-threatening arrhythmias despite optimal medication, surgical, and device therapy 
• Refractory angina not amenable to further revascularisation 
• CPX testing: VO2peak ≤14 ml/kg/min or ≤12 ml/kg/min if on betablockers or high risk of the Heart 
Failure Survival Score with borderline VO2peak 
• Severe ventricular dysfunction (EF <20%) with NYHA Class III-IV despite optimal medical and device 
therapy 
V O2peak, peak oxygen consumption; CPX, cardiopulmonary exercise; EF, ejection fraction; NYHA, New York Heart 
Association 
B. Contraindications 
Absolute 
contraindication 
• Active neoplasm from origins other than skin 
• Severe symptomatic cerebrovascular or peripheral vascular disease 
• Active systemic infection such as HIV 
• Active substance abuse 
Relative 
contraindication 
• Age >70 years old 
• BMI >30 kg/m2 
• Diabetes with end-organ damage or poor glycaemic control (HbA1c >7.5) 
despite optimal effort 
• Severe PHT/ elevated pulmonary vascular resistance 
• Irreversible renal dysfunction (eGFR <40 ml/min) 
• Active tobacco smoking during the previous 6 months 
• Mental retardation or dementia 
• Poor compliance with medical regimens 
May consider 
multi-organ 
transplantation 
• Severe dysfunction of other organs such as lung, kidney and liver 
BMI, body mass index; eGFR, estimated glomerular filtration rate; PHT, pulmonary hypertension 
There is no single test or measurement to determine patients for HTx (Hunt & Frazier, 
1998). Although a CPX test is currently accepted to indicate transplant listing (Mehra et 
al., 2006), a combination of clinical assessment and functional status is also needed 
(De Jonge et al., 2008; Isaac et al., 2011; Katz et al., 2015). Patients with >70 years of 
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age or comorbidities, including obesity, diabetes, HIV, active malignancy and severe 
cerebrovascular disease, as well as a psychosocial status that interferes with the 
patient’s ability to adhere to a long-term medical regimen are considered as 
contraindications to HTx (see Table 1B) (De Jonge et al., 2008; Isaac et al., 2011; Mehra 
et al., 2006). Such contraindications may lead to poor prognosis for survival or poor 
QOL of HTRs (De Jonge et al., 2008; Mehra et al., 2006). Therefore, for the greatest 
outcomes of HTx, it is important to apply those criteria (see Table 1) to all HTx 
candidates.  
3.2 Surgical techniques 
I. Orthotopic heart transplantation 
There are three techniques for orthotopic HTx (OHT), as shown in Table 2 (Antretter & 
Laufer, 2001). 
 
Table 2 Orthotopic heart transplantation techniques 
Orthotopic heart transplantation Anastomosis 
Biatrial (standard) technique Left atrium, right atrium, pulmonary arteries and aorta  
Bicaval technique Left atrium, superior vena cava, inferior vena cava, pulmonary 
arteries and aorta 
Total technique Right-sided left Atrial Cuff, left-sided left Atrial Cuff, superior vena 
cava, inferior vena cava, pulmonary arteries and aorta 
 
By using anastomoses at the mid-atrial levels, the standard biatrial procedure can 
cause atrial geometry abnormality, resulting in post-transplant complications, 
including atrial arrhythmias, atrioventricular valve insufficiency, tricuspid and mitral 
valve regurgitation (Antretter & Laufer, 2001). Because of this, the bicaval and total 
techniques have been developed in an attempt to avoid such problems by altering 
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anastomoses (see Table 2). However, a literature review that compared these three 
OHT techniques found that the bicaval technique had the greatest benefits, including 
improved survival and atrial geometry in addition to a decrease in atrioventricular 
valvular insufficiency, arrhythmias, pacing requirements, vasopressor requirements, 
and hospital stay (Morgan & Edwards, 2005). 
 II. Heterotopic heart transplantation 
Heterotopic HTx (HHT) is performed by connecting the donor heart in parallel with the 
recipient heart to function as a biological biventricular support (Flécher et al., 2013). 
HHT is useful for fixed PHT patients in addition to reduced incidence of hypertension 
(Flécher et al., 2013).  
According to advances in immunosuppression and mechanical circulatory support, the 
use of HHT is less than in the past (Flécher et al., 2013). The bicaval OTH procedure has 
been the preferred technique in many transplant centres globally (Dennell, 2009). 
3.3 Immunosuppressant medications 
To control the destruction of the allograft (i.e. allograft rejection), resulting from the 
recipient's alloimmune response (Deng, 2002), immunosuppressive therapy is needed 
(Deng, 2002; Silva & Cipriano, 2016). However, adverse side effects of 
immunosuppressant medications, such as infections, muscle atrophy, myopathy, 
osteoporosis, renal dysfunction, diabetes and the possible CAV, should be considered 
(Silva & Cipriano, 2016). Table 3 shows commonly used immunosuppressant drugs and 
their major adverse side effects (Deng, 2002; Silva & Cipriano, 2016). 
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Table 3 Commonly used immunosuppressant agents and their major side effects 
Drug Main side effects 
Corticosteroids (Prednisone) Fluid retention, muscle atrophy, myopathy, 
osteoporosis, psychosis 
Azathioprine Marrow suppression, hepatopathy 
Cyclosporine Hyperglycaemia, hypertension, nephrotoxicity, 
electrolyte abnormalities 
Tacrolimus 
Mycophenolate mofetil Hyperglycaemia, hypercholesterolaemia, 
hypertension, peripheral oedema 
Polyclonal antithymocyte globulin Infection, malignancies 
Monoclonal CD3 antibodies 
Sirolimus Hypertriglyceridemia, hypercholesterolaemia, 
hypertension, peripheral oedema 
Everolimus 
 
3.4 Physiology in the early post-heart transplantation 
 I. Denervation of the transplanted heart 
In contrast to the innervation by the autonomic nervous system (ANS) via sympathetic 
and parasympathetic fibres in the normal heart, the transplanted heart is denervated 
because of the dissection of postganglionic neurons during OHT procedure 
(Kobashigawa & Olymbios, 2017). In spite of remaining innervated atria of recipients, 
there are no nerve impulses across the suture line (Kavanagh, 2005; Ramakrishna, 
Jaroszewski, & Arabia, 2009). Therefore, the chronotropic and inotropic responses of 
the transplanted heart must rely on circulating catecholamines from the adrenal 
glands (Nytrøen & Gullestad, 2013; Silva & Cipriano, 2016; Squires, 2011). However, 
intrinsic abilities of the donor heart, including electrical conduction and the Frank-
Starling mechanism, are intact (Ramakrishna et al., 2009).  
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Due to the loss of parasympathetic control, i.e. the lack of vagal nerve innervation, 
donor sinus node activity is responsible for HR generation (Kavanagh, 2005; 
Ramakrishna et al., 2009). As a result, the resting HR is elevated by approximately 30% 
(Dennell, 2009) or 20bpm (Silva & Cipriano, 2016), or increased to approximately 95-
115bpm (Squires, 2011). Due to the high resting HR, the resting stroke volume (SV) in 
HTRs decreases to maintain the resting cardiac output ( Q ), relating to the Frank-
Starling mechanism (Kavanagh et al., 1988). 
In response to exercise, in the normal heart, sympathetic stimulation leads to rapid 
increased HR and then parasympathetic innervation lowers HR to resting levels (Awad 
et al., 2016). Due to the lack of neural control together with the elevated resting HR in 
HTRs, HR cannot draw an immediate response to exercise (Awad et al., 2016; 
Kavanagh, 2005). Firstly, according to an increase in Q  via the Frank-Starling 
mechanism, the contraction of working muscles results in an increase in venous return, 
leading to increased left ventricular (LV) end-diastolic volume, resulting in increased SV 
(Kavanagh, 2005; Squires, 2011). Subsequently, a blunted increase in HR, driven by 
positive chronotropic action of catecholamines, contributes to an increase in Q  after 
the first several minutes of exercise (Silva & Cipriano, 2016; Squires, 2011) despite 
insufficient increased myocardial contractility when compared with those from 
sympathetic control (Dennell, 2009). Peak HR during exercise is slightly lower than 
expected value, i.e. approximately 150 bpm (Silva & Cipriano, 2016; Squires, 2011) or 
80% of normal value (Kavanagh, 2005), and this leads to a decrease in HR reserve in 
HTRs to 30-50 bpm (Kavanagh, 2005). Due to the lack of vagal activity, catecholamines 
also cause a delayed decrease in HR to the resting levels during recovery period 
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(Nytrøen & Gullestad, 2013). It takes 10-15 minutes to decrease plasma catecholamine 
levels after cessation of exercise (Dennell, 2009). 
In terms of the systemic circulation in HTRs, afferent denervation interrupts the 
baroreflex control mechanisms (Silva & Cipriano, 2016). The loss of information to the 
hypothalamus and medulla oblongata results in an impairment of the renin-
angiotensin-aldosterone system to respond to hypervolume (Dennell, 2009). As a 
result, blood volume is increased ≤14%, resulting from fluid retention (Dennell, 2009), 
and this may lead to a mild increase in the resting blood pressure in HTRs (Silva & 
Cipriano, 2016; Squires, 2011). However, systolic blood pressure (SBP) at peak exercise 
is decreased (Silva & Cipriano, 2016) to approximately 80% of normal value (Kavanagh, 
2005). At peak exercise, the lower HR and SBP contribute to a 20% decrease in Q  
(Kavanagh, 2005). 
Additionally, due to sensory afferent denervation, HTRs may not experience angina 
symptoms (Dennell, 2009), which are a warning sign for myocardial ischaemia (Ramzy 
et al., 2005) and this can prevent HTRs from early detection of CAV (Aranda & Hill, 
2000). 
 II. Left ventricular dysfunction 
It has been stated that although most HTRs have a preserved LVEF, an increase in LV 
filling pressure has been implicated in LV diastolic dysfunction (Squires, 2011), 
resulting in a below-normal SV at peak exercise (Silva & Cipriano, 2016; Squires, 2011). 
Despite indirect LV pressure measurements, Kao et al. (1994) found that the HTx group 
had the lower end-diastolic volume index by 14%, resulting in the lower SV index by 
17% at peak exercise, when compared with the normal group. Due to these results, 
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Kao et al. (1994) also claimed that diastolic dysfunction might limit the ability to rely on 
the Frank-Starling mechanism to increase SV. Marconi and Marzorati (2003) stated 
that possible causes of diastolic dysfunction in HTRs may be a combination of a 
mismatch between the size of the donor heart and the body of recipients, a number of 
rejections, hypertension, and myocardial ischaemia, resulting from CAV. 
 III. Pulmonary function 
Although lung volume, airway function and pulmonary haemodynamic abnormalities, 
caused by severe chronic HF, can be recovered to nearly normal in most HTRs, 
approximately 40% of HTRs (Squires, 2011) experience an impairment of alveolar gas 
diffusion, which may be due to pulmonary microvascular injury before surgery 
(Marconi & Marzorati, 2003). A below-normal increase in tidal volume during exercise 
may result from respiratory muscle weakness, hypoperfusion, deconditioning or the 
effect of long-term corticosteroid administration (Brubaker, Brozena, Morley, Walter, 
& Berry, 1997). In addition, ventilatory efficiency during exercise ( V E/ V CO2slope) may 
be lower than normal (Squires, 2011). However, most HTRs still have normal value of 
arterial oxygen saturation at rest and during exercise (Squires, 2011). 
 IV. Muscle function and structure 
Adverse effects on skeletal muscles from chronic HF during the pre-transplant period, 
including impaired vasodilation during exercise due to endothelial dysfunction, 
decreased fibre cross-sectional area, decreased capillary density, reduced content of 
mitochondria, decreased oxidative enzymes, increased anaerobic enzymes and 
conversion of slow-twitch muscle fibres towards fast twitch muscle fibres, remain 
apparent in HTRs (Braith & Edwards, 2000; Marconi & Marzorati, 2003; Squires, 2011).  
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Kao et al. (1994) found that, at rest and submaximal exercise, arteriovenous oxygen 
difference [(a- v )O2 diff] was normal in the HTx group; on the other hand, at maximal 
exercise, (a- v )O2 diff was decreased by 24%, when compared with the normal group. 
This may be caused by an impairment of oxidative capacity metabolism and peripheral 
oxygen delivery, relating to decreased capillary blood. Moreover, an above-normal 
increase in plasma lactate concentrations at peak exercise indicates metabolic 
insufficiency of skeletal muscle in HTRs (Braith & Edwards, 2000). 
The use of corticosteroids, i.e. immunosuppressive agents (see Table 3), can lead to 
muscle wasting and decreased bone formation in HTRs. As for muscle atrophy, this is 
induced by corticosteroids by inhibiting the amino acid transport into muscles, 
resulting in protein synthesis limitation, and inhibiting myogenesis, leading to protein 
catabolism (Schakman, Gilson, & Thissen, 2008). Corticosteroids also result in 
osteoporosis by decreasing the rate of bone formation, the number of osteoblasts and 
osteocytes and their functions (Briot & Roux, 2015). 
3.5 Major post-transplant complications 
 I. Allograft rejection 
Allograft rejection can damage myocytes, leading to myocyte necrosis, which may 
result in LV dysfunction and HF (Squires, 2004). As regards immunosuppressant 
therapy (see section 3.3), graft rejection can result from underimmunosuppression; on 
the other hand, overimmunosuppression may cause infections to all organ allograft 
recipients (Hunt, 1998). A routine endomyocardial biopsy is required to detect 
rejection and is also useful to optimise intensity of immunosuppression (Dennell, 2009; 
Hunt, 1998; Squires, 2004). In the context of CR, the result of biopsy is also essential 
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for adjusting exercise programmes for HTRs (Dennell, 2009). Standardised acute 
rejection grading scale is outlined in Table 4 (Squires, 2004). 
 
Table 4 Grading of acute rejection 
Grade Level of rejection 
0 No rejection 
1 Mild rejection 
1A Focal infiltration without necrosis 
1B Diffuse but sparse infiltration, without necrosis 
2 Moderate rejection 
 One focus only with aggressive infiltration ± focal myocyte damage 
3 Moderate rejection 
3A Multifocal aggressive infiltration ± myocyte damage 
3B Diffuse inflammatory process with necrosis 
4 Severe rejection 
 Diffuse aggressive polymorphous infiltrates with necrosis 
 
To prevent permanent damage to the myocardium, HTRs should be advised to not to 
exercise during severe rejection until the episode is resolved (Dennell, 2009). However, 
patients can continue exercise at current levels without progression during moderate 
rejection and slowly progress during an episode of mild rejection (Dennell, 2009). 
II. Infection 
A high level of immunosuppression is related to opportunistic infections in HTRs (Hunt, 
1998). The major serious infection in HTRs is affected by cytomegalovirus (CMV) (Deng, 
2002). Due to being the leading causes of death in the first year after transplantation 
(Lund et al., 2017), a therapeutic approach that focuses on infection management is 
useful for survival after HTx (Hunt, 1998). Moreover, to detect the first signs of an 
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infection, routine temperature monitoring is required (Association of Chartered 
Physiotherapists in Cardiac Rehabilitation [ACPICR], 2015). 
III. Cardiac allograft vasculopathy 
CAV, i.e. accelerated graft coronary disease (Squires, 2004), is a major long-term 
survival limitation of HTRs (Lund et al., 2017). Endothelial injury and fibroproliferative 
cellular responses, stimulated by vascular inflammation through either immunologic or 
nonimmunologic factors, leads to excessive tissue repair responses, resulting in 
circumferential intimal thickening (Chih, Chong, Mielniczuk, Bhatt, & Beanlands, 2016) 
and, eventually, blocking the coronary vessels, particularly the intramyocardial vessels 
(Ramzy et al., 2005). The immune response to the allograft is the factor that develops 
CAV in addition to immunosuppressant drugs, ischemia-reperfusion injury, CMV 
infection, and vascular risk factors, such as obesity, hypertension, hyperglycaemia and 
hyperlipidaemia (Chih et al., 2016; Squires, 2004).  
Due to the limited treatment for CAV, re-transplantation is the only effective 
treatment option for severe CAV (Ramzy et al., 2005). Therefore, prevention of CAV 
through immune and nonimmune risk factors, such as optimising immunosuppressive 
therapy and lipid-lowering drugs together with lifestyle changes, is important for HTRs 
(Ramzy et al., 2005). 
4. Exercise performance in heart transplant recipients 
Chronotropic incompetence, i.e. an inadequate HR response to exercise (Brubaker & 
Kitzman, 2011), due to denervation, LV dysfunction, pulmonary limitations and 
abnormalities of skeletal muscle function and structure (see section 3.4) are associated 
with decreased VO2peak and exercise intolerance in HTRs (Braith & Edwards, 2000; 
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Marconi & Marzorati, 2003). These abnormal physiological responses are also cited in 
Nytrøen and Gullestad (2013) as possible factors that may be related to a decrease in 
exercise capacity in HTRs (see Table 5). 
 
Table 5 Possible factors related to reduced exercise capacity in heart transplant recipients 
Central factors Peripheral factors 
Reduced cardiac output 
Chronotropic incompetence 
Reduced stroke volume 
Systolic dysfunction 
Diastolic dysfunction 
Pulmonary dysfunction 
Pulmonary hypertension 
Pulmonary congestion 
Reduced skeletal muscle function 
Reduced muscle mass 
Reduced muscle strength 
Reduced capillary density 
Reduced oxidative capacity 
Reduced mitochondrial function 
Impaired vasodilatory capacity 
Endothelial dysfunction 
Corticosteroid induced myopathy 
Deconditioning 
 
A study of exercise capacity in well-trained HTRs (n =7), kidney transplant recipients 
(KTRs, n =6) and control subjects (CSs, n =6) showed that HTRs had the significantly 
lowest performance when compared with KTRs and CSs (maximal oxygen consumption 
[ VO2max] [41.5±4.0, 52.0±8.7 and 50.6±9.0 ml/kg/min, respectively], maximal 
treadmill speed [9.9±1.2, 12.7±1.9 and 15.5±1.5 km/h, respectively] and HR reserve 
[65±17, 101±12 and 110±11 bpm, respectively], P < .05) (Richard et al., 2005). 
Additionally, a study of a CPX test in the early, i.e. after HTx <1 year, and the late HTR 
group, i.e. after HTx for 10 years, revealed that although the mean HR reserve of the 
early HTR group was lower than that of the late HTR group (39±15 vs. 58±19 bpm, 
respectively, P = .049) in addition to a decrease in HR recovery in the late HTR group (-
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6.0±4.7% at the first minute and -15.5±2.4% at the second minute), there was no 
significant difference in VO2peak between the two groups (23.4±4 vs. 21.8±5 
ml/kg/min, respectively, P = .56) and time of exercise testing (14±3 vs. 13±3 min, 
respectively, P = .95) (Carvalho et al., 2013). This means that despite an improvement 
in HR reserve and HR recovery, exercise capacity of HTRs cannot be restored over time. 
However, significant differences of recipients’ characteristics, i.e. age (P = .003) and 
BMI (P = .049), should be taken into consideration and are clearly limitations of this 
study. 
Furthermore, Nytrøen and Gullestad (2013) also state that co-morbidities, smoking, 
anxiety and depression and reduced HRQoL may limit exercise performance in HTRs. 
5. Exercise-based cardiac rehabilitation for heart transplant recipients 
Early mobilisation can be started as soon as HTRs are extubated after surgery (AACVPR, 
2013; Dennell, 2009). Regarding inpatient ET, individuals may begin with exercise in 
bed, such as passive range-of-motion exercises for upper and lower extremities and 
active leg exercise, and can gradually progress to seated exercise, standing exercise 
and walking (AACVPR, 2013; Dennell, 2009). Exercise with machines, including cycle 
ergometry without adding resistance and treadmill walking at a slow pace, may be 
commenced, depending on an improvement of the individual’s performance (AACVPR, 
2013; Kavanagh, 2005) and episodes of rejection (see section 3.5) (AACVPR, 2013; 
Dennell, 2009). 
As for exercise prescription for outpatients, while HR-based intensity is not 
appropriate for HTRs due to chronotropic incompetence, the use of rating of perceived 
exertion (RPE) scale is recommended, i.e. 11-14 on the Borg RPE scale (AACVPR, 2013; 
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ACPICR, 2015; ACSM, 2018). It is important to note that due to the delayed HR 
responses, caused by catecholamines, HTRs need a longer time to warm-up and cool-
down, i.e. 10-15 minutes each (ACPICR, 2015). 
ET for HTRs should include not only aerobic exercise, but also resistance training to 
counteract the adverse side effects of immunosuppressant therapy on bone and 
skeletal muscle (see section 3.4) (AACVPR, 2013; ACSM, 2018). Braith et al. (2003) 
reported that despite there being a significant lower (P ≤ .05) total body bone mineral 
density (BMD) of HTRs, who received cyclosporine, prednisone and azathioprine, at 2-
month post-HTx (-2.7±1.0%) when compared with pre-HTx values, no significant 
difference values (-0.9±0.2%) were found in HTRs who participated in 6-month 
resistance training and received alendronate. Although no subjects participated in 
resistance training alone, this study may indicate that adding resistance ET to an anti-
osteoporosis regimen can reverse steroid-induced bone loss in HTRs. 
Kobashigawa et al. (1999) compared the effects of ET in 14 HTRs (the exercise group), 
who participated in exercise rehabilitation programmes (i.e. strengthening, flexibility 
and moderate-intensity aerobic exercises), with 13 HTRs (the control group), who 
participated in non-formal exercise sessions with written exercise guidelines between 
1- and 6-month post-transplant. The exercise group showed superior outcomes (mean 
difference), when compared with the control group, in VO2peak (4.4 vs. 1.9 ml/kg/min, 
respectively, P = .01), the ventilatory equivalent for carbon dioxide ( V E/ V CO2) (-13 vs. 
-6, respectively, P = .02) and the sit-to-stand rate within 1 minute (i.e. the modified 
muscle strength testing) (13.3 vs. 5.6 no./min, respectively, P = .02) (Kobashigawa et 
al., 1999). This study revealed that HTRs who received individualised exercise 
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programmes had an increase in exercise capacity and muscle performance, which can 
indicate improved QOL (Kobashigawa et al., 1999), in spite of the lack of the non-
exercise group.  
Comparison between HTRs with regular exercise (the training group; 7 men) and non-
exercise (the non-training group; 6 men) and healthy participants (the control group; 6 
men) were carried out by Schmidt et al. (2002). While the training group participated 
in ET programme with 2-3 day/week of stationary cycling for ≥6 months, a sedentary 
lifestyle with exercise ≤1 day/week was defined as the non-training group (Schmidt et 
al., 2002). A regular aerobic exercise not only increased VO2peak significantly (P = .05) 
by 16±8% in the training group, but it also improved vascular function by increasing 
flow-mediated vasodilation (percentage difference: 8.4±2.2% vs. 7.1±2.4% vs. 
1.4±0.8% for the control, training and non-training groups, respectively, P < .05) 
(Schmidt et al., 2002). This means that aerobic exercise may improve endothelial 
function (EnF) in HTRs, although it remains inferior to age-matched healthy individuals. 
However, the small size of each group and the only male participants in this study 
limited the strength of the results. 
A study that included 43 HTRs showed that supervised aerobic and strength training 
for 12 weeks resulted in the greater increase in VO2peak by 3.11 ml/kg/min (95% CI 
1.2-5.0, P = .003), chest‐press and leg‐press strength by 10.4 kg (5.2-15.5) and 34.7 kg 
(3.7-65.6), respectively, and leg and total lean tissue mass (LTM)  by 0.78 kg (0.31-1.3) 
and 1.34 kg (0.34-2.3), respectively, in training HTRs, compared with no-training HTRs 
(Haykowsky, Taylor, Kim, & Tymchak, 2009). However, no improved LV systolic 
function and brachial artery EnF in this study indicated that increased exercise capacity 
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of HTRs may predominantly rely on peripheral skeletal muscle adaptations through 
oxygen utilization improvement (Haykowsky et al., 2009). 
Decreased resting HR (MD -5 [95% CI (-9)-0], P = .04), increased peak HR (5 [0-10], P = 
.035) and increased HR reserve (10 [4-16], P = .002) were found in HTRs after 
performing HIIT (Nytrøen et al., 2012). This means that ET may alleviate chronotropic 
incompetence in HTRs.  
Due to effects of exercise on reduced arterial wall thickness (Thijssen, Cable, & Green, 
2012) and vascular risk factors, including obesity and plasma lipids (Swift et al., 2013), 
which are possible factors to develop CAV (see section 3.5), exercise-based CR in HTRs 
may reduce the progression of CAV. Thottam et al. (2013) found that CR was related to 
decreased 5-years progression of CAV in HTRs when compared with HTRs without CR 
(85% vs. 76%, respectively, P = .024) despite a significant difference of recipient age 
(54±12 vs. 58±11, respectively, P = .001). Additionally, by using intravascular 
ultrasonography, Nytrøen et al. (2013) revealed that HTRs participated in HIIT had a 
smaller rate of CAV progression when compared with control participants. The mean 
increase in percent atheroma volume (0.9% [95% CI (-0.3)-1.9], total atheroma volume 
(0.3 mm3/mm [0.0-0.6] and maximal intimal thickness (0.02 mm [(-0.01)-0.04] in the 
HIIT group was lower than that of the control group (P = .021, .020 and .054 [marginal 
significance], respectively) (Nytrøen et al., 2013). 
However, regarding studies of HIIT by Nytrøen et al. (2012) and Nytrøen et al. (2013). 
HTRs who participated in standard programmes were defined as control participants. 
In this way, non-exercise participants are needed to determine whether usual exercise 
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or HIIT results in reversal of chronotropic incompetence and reduce the progression of 
CAV in HTRs, respectively. 
The latest Cochrane review of exercise-based CR in HTRs (Anderson et al., 2017) 
reported the greater VO2peak improvement by 2.49 m/kg/min (95% CI 1.63-3.36) for 
patients participating in ET programme versus non-exercise HTRs and 2.30 ml/kg/min 
(0.59-4.01, P < .001) for those who undertook HIIT versus continued moderate-
intensity training (CMIT). As for HRQoL, an improvement from ET cannot be concluded 
due to the variation in methods and outcomes of each study. Also, in terms of HIIT 
versus CMIT, there were no statistically significant differences between groups 
(Anderson et al., 2017). Due to the short periods of follow up, i.e. a median of 12 
months, this may not be adequate duration for detecting any changes from HTRs. 
There are very limited studies which have performed the long-term of ET after HTx. 
Despite the small sample size, Kavanagh et al. (2003) have successfully investigated a 
study of 12-year follow-up in 20 surviving HTRs who received the 16-month ET 
programme and were advised to continue exercise from their final prescription, 
compared with the age-matched healthy controls. In spite of an increase in VO2peak 
from 22.2±4 to 27.9±7 ml/kg/min in HTx survivors at 16 months, VO2peak decreased to 
23.7±6 ml/kg/min at 12 years, accounting for 0.39 ml/kg/min/year (Kavanagh et al., 
2003). Due to the similar rate of decline in the controls group, i.e. 0.37 
ml/kg/min/year, this may be caused by the normal ageing process (Kavanagh et al., 
2003). Moreover, although lean body mass of HTRs increased from 56.7±5 to 62.3±8 kg 
at 12 years, it was lower than the controls (65.7±7 kg); therefore, resistance training is 
needed (Kavanagh et al., 2003).  
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6. Conclusion 
Although survival after HTx has increased over time, unique physiological changes due 
to cardiac ANS denervation, immunosuppressant therapy and prolonged de-
conditioning from chronic HF result in abnormalities, such as chronotropic 
incompetence and peripheral muscle dysfunction, leading to exercise intolerance in 
HTRs. ET not only improves VO2peak and chronotropic responses to exercise in HTRs, 
but it also counteracts the adverse side effects of immunosuppressive agents on 
skeletal muscle performance. The provision of exercise-based CR, which consists of 
aerobic, resistance and flexibility exercise, is advantageous for HRTs by improving 
exercise capacity in addition to reduced progression of CAV through HIIT. However, the 
fact that the normal ageing process may affect long-term outcomes in HTRs needs to 
be taken into consideration. 
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1. The appropriate journal for publishing a study 
The aim of this review was to examine effectiveness of exercise interventions in 
patients post cardiac transplantation, hence it is appropriate for publication in a 
medical, health science or education journal, covering articles on aspects of heart 
transplantation. The Journal of Heart and Lung Transplantation covers research in the 
field of cardiac and pulmonary transplantation. The scope of its content is not only 
limited to surgery but covers allied health sciences in the field of cardiopulmonary 
transplantation, including exercise intervention, physiotherapy and cardiac 
rehabilitation. Several articles cited in the review were found in this journal during 
database searching, which highlights its eminence and impact in the field. 
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2. Abstract  
Objectives  
The aim of this systematic review is to determine the effects and safety of exercise-
based cardiac rehabilitation (CR) on exercise capacity in elderly patients who undergo 
heart transplantation (HTx). 
Methods 
Relevant studies of exercise-based CR in heart transplant recipients (HTRs) aged ≥55 
years were systematically searched through PubMed, the Cumulative Index to Nursing 
and Allied Health Literature (CINAHL) and Web of Science. The Physiotherapy Evidence 
Database (PEDro) scale was used to determine study quality. 
Results 
Five studies, which included four randomised controlled trials (RCTs) and one 
uncontrolled trial (UCT), met the inclusion criteria for the review. The selected studies 
had participants with a median age of 57 years (range 55-60.6 years). The exercise 
programmes conducted in the studies had a training duration ranging from 8-48 
weeks. Aerobic and strength training were used in all studies. After the training 
periods, a significant increase in peak oxygen consumption ( VO2peak) was reported in 
the majority of studies. Three RCTs reported improved lower extremity muscular 
strength. When compared with controls, increased peak heart rate (HR) in training 
participants was found in only one RCT with a 1-year programme of high-intensity 
interval training (HIIT). All studies did not show any significant changes in 
cardiovascular function and no adverse events were reported. 
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Conclusion 
Exercise-based CR is safe and can improve exercise capacity in elderly HTRs who are 
clinically stable through an improvement in peripheral muscular performance. A ≥1-
year HIIT programme is likely to be more effective than usual exercise by improving 
peak HR in elderly HTRs. 
 
Keywords: heart transplant, elderly, exercise training, exercise capacity 
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3. Introduction 
Although people living with and dying from heart failure (HF) are increasing, there 
have been effective treatments that can improve quality of life (QOL) and survival of 
these patients (Ponikowski et al., 2014). As for end-stage HF, HTx is the gold standard 
treatment (Yancy et al., 2013). The comparison of one-, three- and five-year survival 
rates of adult HTRs in the United States between the 2013 Annual Data Report (88.1%, 
81.3% and 75.3%, respectively) (Colvin-Adams et al., 2015) and the 2016 report 
(90.1%, 83.5% and 78.3%, respectively) (Colvin et al.,2018) indicates that the survival 
rates of adult HTRs have improved. Also, the incidence of allograft rejection after 
transplant has decreased due to an improvement of immunosuppressive modalities 
(Lund et al., 2017). HTx not only reduces mortality of HF patients with high risk of dying 
(Deng, De Meester, Smits, Heinecke, & Scheld, 2000), but also improves overall QOL 
compared with patients on the waiting list (Mantovani et al., 2016). 
Between 1982-1998 and 2009-6/2016 periods, data from the Registry of the 
International Society for Heart and Lung Transplantation (ISHLT) revealed that 
although patients aged 40-59 years were a large number of HTRs, this proportion 
declined from 59.82% to 43.86% for each period, respectively; on the other hand, a 
growth from 16.37% to 26.19% of 60-69 years of age and from 0.27% to 1.82% of ≥70 
years of age for each period, respectively, indicated that older recipients increased 
gradually (Lund et al., 2017). Despite the extended upper age limit for HTx candidates 
to 70 years old (Mehra et al., 2006), the outcomes of HTx in elderly patients are 
controversial. Elderly HTRs have been reported to have poorer survival (Cooper et al., 
2016; Lund et al., 2017; Samsky et al., 2013; Sponga et al., 2016; Tjang, van der 
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Heijden, Tenderich, Körfer, & Grobbee, 2008) in addition to higher infection rate and 
increased hospital stay (Weiss, Nwakanma, Patel, & Yuh, 2008), and higher incidence 
of rejection (Jamil et al., 2017) compared to that of younger counterparts. By contrast, 
it has been argued that elderly HTRs have fewer rejection episodes (Baron et al., 1999; 
Bull et al., 1996; Demers et al., 2003; Weiss et al., 2008; Zuckermann et al., 2003) as 
well as equivalent morbidity and mortality (Baron et al., 1999; Blanche et al., 1996; 
Blanche et al., 2001; Demers et al., 2003; Jamil et al., 2017; Zuckermann et al., 2003) 
compared with those in younger counterparts. 
The denervated transplanted heart leads to unique characteristics, such as 
chronotropic incompetence, left ventricular (LV) dysfunction, and abnormal skeletal 
muscle function and structure, resulting in decreased exercise capacity in HTRs (Braith 
& Edwards, 2000; Marconi & Marzorati, 2003; Nytrøen & Gullestad, 2013). Exercise 
capacity has been claimed a strong predictor of the risk of death in both healthy 
individuals and patients with cardiovascular disease (CVD) (Myers et al., 2002). 
Therefore, improving exercise capacity is important to reduce mortality for HTRs. 
In 1999, Kobashigawa et al. stated that improved exercise capacity and QOL in HTRs 
may result from the early introduction of exercise training (ET) after HTx. Moreover, a 
2017 Cochrane review showed that exercise-based CR can improve exercise capacity in 
HTRs, who had a median age of 54.4 years (range 45-60.6 years) (Anderson et al., 
2017). Although the advantage of exercise-based CR in HTRs on increased exercise 
capacity has been documented in the latest Cochrane review, there is less focus on 
HTRs of advanced age, which are increasing over time; this group deserves further 
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attention. Therefore, the purpose of this current systematic review is to determine the 
effects and safety of exercise-based CR on exercise capacity in elderly HTRs. 
4. Methods 
Due to being a dissertation of Master’s degree, this systematic review has been 
conducted by a single reviewer. 
4.1 Search strategy 
Three databases, namely PubMed, CINAHL and Web of Science, were used to search 
for articles regarding HTx, exercise-based CR and exercise capacity. Search terms 
included cardiac or heart transplantation, cardiac rehabilitation, exercise training, 
exercise programme, physiotherapy, exercise capacity, exercise performance and 
oxygen consumption (see Appendix A). To avoid leaving out any relevant published 
articles, no filters were applied for age ranges of study population, study design, 
publication year or language. The search strategy was completed in July 2018. 
4.2 Selection criteria 
As for inclusion criteria, studies of exercise-based CR in HTRs were included. Exercise-
based interventions could be ET alone or ET in addition to other components of 
comprehensive CR programme, such as health education and psychosocial health 
components. Furthermore, ET could be a supervised or unsupervised structured 
programme as well as a centre- or home-based programme for inpatients or 
outpatients. If the control group was included, participants in this group must not have 
received structured exercise above their normal pre-study routine but may have 
received standard medical care, non-exercise interventions of comprehensive CR, 
unstructured exercises or general advice on physical activity. 
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Regarding types of participants, older HTRs were adopted. Advanced age in HTx have 
been reported as ≥55 years (Borkon et al., 1999; Tjang et al., 2008), ≥60 years (Baron 
et al., 1999; Bull et al., 1996; Demers et al., 2003; Weiss et al., 2008; Zuckermann et al., 
2003), ≥65 years (Blanche et al., 1996; Jamil et al., 2017; Samsky et al., 2013) and ≥70 
years (Blanche et al., 2001). Due to the lack of a clear definition of elderly HTRs, studies 
that had the average age of participants ≥55 years were selected in this systematic 
review to maximise outcome data. 
In terms of exclusion, studies were excluded on the following criteria: no full-text 
available, not published in English and the average age of participants <55 years, 
particularly the training group. Moreover, studies that included control participants 
who received ET above their normal pre-study routine were also excluded. 
4.3 Selection of studies 
Firstly, after removing duplicate articles, titles and abstracts, resulting from the search 
strategy, were initially screened on the basis of the inclusion criteria. Then, the full text 
of the remaining articles was assessed for eligibility with the full selection criteria. 
Finally, the articles that met the full eligibility criteria were included for data 
extraction. 
4.4 Data extraction  
Extracted data included study design, the country, source of funding, objectives, study 
setting (location), total duration of study, number of participants, number of drop 
outs, participants’ mean age, time since HTx, component of the intervention, content 
of the exercise intervention (mode or type of exercise, intensity, frequency, and time 
per session), exercise testing method, outcomes on exercise capacity and all relevant 
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outcomes to exercise (e.g. muscle performance), adverse events, results with 
statistical significance, key points of discussion and conclusions. 
4.5 Assessment of study validity 
Study validity were assessed by using the PEDro scale, which consists of 11 items, 
including stated eligibility criteria, the use of random and concealed allocation 
procedure, baseline comparability, blinding of all subjects, therapists and assessors, 
adequate follow-up, the use of intention-to-treat analysis, reporting the results of 
between-group statistical comparisons, and providing both point estimates and 
variability (see Appendix B) (PEDro, 1999). A total score out of 10 comes from each 
satisfied item, except for item 1, which relates to external validity (PEDro, 1999). 
5. Results 
The results of the search through databases were 1972 articles. After removing 861 
duplicates, another 1088 articles were excluded based on titles and abstracts. The 
remining 23 articles were retrieved to assess the full-text documents. Then, 18 articles 
were removed due to participant age (n = 12), non-full-text articles (n = 5) and non-
English article (n = 1) (see Appendix C). Finally, a total of five studies met the inclusion 
criteria and were included in this systematic review. As for the validity of included 
studies, the PEDro scores ranged from 3/10 to 7/10 (see Appendix D). Summary of the 
study selection process is shown in Figure 1. Also, details of included studies are listed 
in Appendix E. 
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Table 6 Characteristics of the included studies on study groups 
Study Study design Number of participants Age of participants Time since HTx Setting Intervention Duration 
Haykowsky, 
Taylor, Kim, & 
Tymchak (2009) 
RCT Training n = 22 
Drop out (% of drop out 
within group) n = 1 (4.5%) 
Training (mean ± SD): 
57 ± 10 years 
 
Training (mean ± SD): 
5.4 ± 4.9 years 
Centre Training: 
- Aerobic and strengthening exercises 
12 weeks 
Control n = 21 
Drop out (% of drop out 
within group) n = 2 (9.5%) 
Control (mean ± SD): 
59 ± 11 years 
Control (mean ± SD): 
4.4 ± 3.3 years 
Control: 
- No training and exercise guidelines 
- Continue usual activities of daily 
living 
Kobashigawa et 
al. (1999) 
RCT Training n = 14 
Drop out (% of drop out 
within group) n = NS 
Training (mean ± SD): 
55 ± 8 years 
Control: 0.04 years Centre Training: 
- Aerobic, strengthening and 
flexibility exercises 
- Written home exercise guidelines 
24 weeks 
Control n = 13 
Drop out (% of drop out 
within group) n = NS 
Training (mean ± SD): 
50 ± 12 years 
Control: 0.04 years Control: 
- No formal, supervised exercise 
sessions 
- Written home exercise guidelines 
Rustad, Nytrøen, 
Amundsen, 
Gullestad, & 
Aakhus (2014) 
RCT Training n = 26 
Drop out (% of drop out 
within group) n = 2 (7.7%) 
Training (median 
[range]): 56 (20-72) 
years 
Training (median 
[range]): 5 (1-8) years 
Centre Training: 
- Aerobic exercise (HIIT) 
48 weeks 
Control n = 26 
Drop out (% of drop out 
within group) n = 2 (7.7%) 
Control (median 
[range]): 58 (19-71) 
years 
Control (median 
[range]): 4 (1-7) years 
Control: 
- Requested to continue routine 
exercise 
Wu et al. (2008) RCT Training n = 14 
Drop out (% of drop out 
within group) n = 2 (14.3%) 
Training (mean ± SD): 
60.6 ± 6.2 years 
Training (mean ± SD): 
1.6 ± 1.8 years 
Home Training: 
- Aerobic and strengthening exercises 
8 weeks 
Control n = 23 
Drop out (% of drop out 
within group) n = 4 (17.4%) 
Control (mean ± SD): 
51.6 ± 12.8 years 
Control (mean ± SD): 
2.6 ± 1.9 years 
Control: 
- No training  
- Keep usual activity lifestyle 
Haykowsky et al. 
(2005) 
UCT Training n = 18 
Drop out (% of drop out 
within group) n = 1 (4.5%) 
Training (mean ± SD): 
57 ± 6 years 
Control: 0.08 years Centre Training: 
- Aerobic and strengthening exercises 
12 weeks 
No control group No control group No control group No control group 
HIIT, high-intensity interval training; HTx, heart transplantation; NS, not stated; RCT, randomised controlled trial; UCT, uncontrolled trial 
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5.1 Study design and population 
Table 6 shows description of the study design and participants of the five included 
studies, which consisted of four RCTs (Haykowsky, Taylor, Kim, & Tymchak, 2009; 
Kobashigawa et al., 1999; Rustad, Nytrøen, Amundsen, Gullestad, & Aakhus, 2014; Wu 
et al., 2008), and one UCT (Haykowsky et al., 2005). 
The training duration ranged from 8 weeks to 48 weeks (1 year). Most studies used a 
centre-based exercise programme for the training group, while one study used home-
based exercises (Wu et al., 2008). However, participants in Kobashigawa et al. (1999) 
received written exercise guidelines to exercise at home. 
A median age of participants participated in the exercise programmes was 57 years 
(range 55-60.6 years) with a median time since HTx of 1.6 years (range 0.04-5.4). Drop-
out participants were reported in three studies (Haykowsky et al., 2009; Rustad et al., 
2014; Wu et al., 2008). The percentage of drop outs ranged from 4.5% to 14.3% for the 
training group and ranged from 9.5% to 17.4% for the control group. 
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Table 7 Summary of exercise interventions of the included studies 
Study Type of 
exercise 
Training method/ 
equipment 
Frequency Intensity Time per session 
Haykowsky, 
Taylor, Kim, & 
Tymchak (2009) 
Aerobic  Treadmill and cycle - First 8 weeks: 5 days/week 
- Final 4 weeks: 3 days/week 
for CT; 2 days/week for IT 
- First 8 weeks: 60-80% V O2peak 
- Final 4 weeks: 80% V O2peak for CT; 
90-100% baseline PO (cycle) for IT 
- First 8 weeks: 30-45 minutes 
- Final 4 weeks: 45 minutes for CT; 15-37.5 
minutes for IT 
Strength Upper and lower extremity 
strength training 
2 days/week 50% of maximal strength 1-2 sets of 10-15 repetitions 
Kobashigawa et 
al. (1999) 
Aerobic  Treadmill, bicycle or arm 
ergometer 
- For centre-based: initially, 1-3 
times/week and gradually 
reduced to 1 time/ 2 weeks 
Moderate intensity (due to patient’s 
tolerance) 
≥ 30 minutes (for CT) 
Strength Closed-chain resistive and 
abdominal exercises 
NS NS 
Flexibility Chest expansion and 
thoracic mobility exercises 
NS NS 
Rustad, Nytrøen, 
Amundsen, 
Gullestad, & 
Aakhus (2014) 
Aerobic Treadmill (walking or 
running uphill) 
3 sessions/week - Intervals: 85-95% of peak HR 
- Active pauses: RPE 11–13 
≥ 38 minutes  
(10-minute warm-up; 4 x 4-minute 
intervals with 3-minute active pause; NS 
cool-down) 
CT, continuous training; HR, heart rate; IT, interval training; NS, not stated; PO, power output; RPE, rating of perceived exertion; V O2peak, peak oxygen consumption 
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Table 7 Summary of exercise interventions of the included studies (continued) 
Study Type of 
exercise 
Training method/ 
equipment 
Frequency Intensity Time per session 
Wu et al. (2008) Aerobic 
 
Walking and stepping 
exercises 
≥ 3 times/week For walking: RPE 12-14 (equivalent to 
60-70% V O2peak) 
≥ 35 minutes 
(5-minute warm-up; NS time of strength 
training; walking 15-20 minutes and 
stepping 10 minutes; 5-minute cool-down) 
Strength Upper and lower extremity 
strength training 
NS 
Haykowsky et al. 
(2005) 
Aerobic 
 
Treadmill and/or bicycle 5 days/week RPE 12-14 30-40 minutes 
Strength Lower extremity resistance 
training 
NS 50% of maximal strength, 
progressively increased as tolerated 
3-5 sets of 10 repetitions 
CT, continuous training; HR, heart rate; IT, interval training; NS, not stated; PO, power output; RPE, rating of perceived exertion; V O2peak, Peak oxygen consumption 
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5.2 Exercise training 
Description of exercise interventions of the included studies is outlined in Table 7. All 
studies used aerobic and strength training. Also, one study added flexibility exercise 
into the training programme (Kobashigawa et al., 1999). 
As for the aerobic exercise, treadmill walking and static cycling were most commonly 
used. The reported training intensity ranged widely across studies. Moderate intensity 
was set for continuous training (CT) by using a percentage of VO2peak, which was 60-
80% VO2peak (Haykowsky et al., 2009), and the Borg's rating of perceived exertion 
(RPE) 6-20 scale, which was RPE 12-14 (Haykowsky et al., 2005; Wu et al., 2008), as 
well as individualised intensity (Kobashigawa et al., 1999). The use of HIIT was also 
reported in two trials, which based intensity during the work periods on 85-95% of 
peak HR for walking or running uphill on a treadmill (Rustad et al.,2014) and 90-100% 
of baseline power output (PO) for cycling (Haykowsky et al., 2009). The frequency and 
session length ranged from 3 to 5 days/week and from 30 to 45 minutes, respectively. 
Strengthening exercises for upper (e.g. chest press and arm curls) and lower (e.g. leg 
press, bridging and half-squats) extremities were most commonly used. Abdominal 
exercise was also included in one study (Kobashigawa et al., 1999). Two studies 
reported that strength training was performed in the same training sessions with 
aerobic exercise but did not state session length and intensity (Kobashigawa et al., 
1999; Wu et al., 2008). Two studies reported dose of training with intensity of 50% of 
maximal strength, 1-5 sets with 10-15 repetitions (Haykowsky et al., 2005; Haykowsky 
et al., 2009). However, only the study of Haykowsky et al. (2009) reported the strength 
training frequency of 2 days/week. 
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5.3 Results of exercise capacity testing 
According to Table 8, a maximal exercise test was used to assess exercise capacity. A 
bicycle ergometer was most commonly conducted, while a treadmill was only used in 
one study (Rustad et al., 2014). VO2peak and peak HR were reported as exercise 
capacity outcomes in the majority of trials. Peak workload, peak PO, peak respiratory 
exchange ratio (RER), resting HR, resting systolic blood pressure (SBP), peak SBP and 
minute ventilation ( V E) were also the most commonly reported outcomes. 
Regarding the comparison of each variable between baseline and after interventions of 
the training participants (see Table 8). All studies showed a positive effect on exercise 
capacity. The majority of studies reported an increase in both VO2peak and peak HR 
after the training period. Two studies reported a significant increase in VO2peak and 
peak HR (Haykowsky et al., 2005; Rustad et al., 2014). One study also reported an 
increase in both VO2peak and peak HR by the percentage change (Kobashigawa et al., 
1999). The mean increase in VO2peak and peak HR ranged from +3.2 to +6.0 
ml/kg/min and from +4 to +25 bpm, respectively. Moreover, a significant increase in 
peak PO was reported by Haykowsky et al. (2005). Also, increased peak workload, peak 
SBP and V E were reported due to increased change after interventions. As for resting 
HR and resting SBP, there were conflicting data between two trials (Kobashigawa et al., 
1999; Wu et al., 2008). 
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Table 8 Summary results of exercise capacity testing: Comparison between baseline and post-
interventions of the training subjects 
Study Test method/ 
equipment 
Parameter Baseline Post-
training 
Mean change 
Haykowsky, 
Taylor, Kim, & 
Tymchak (2009) 
Maximal exercise 
test/ bicycle 
ergometer 
V O2peak (ml/kg/min) 21.2 ± 7.3 24.7 ± 8.8 +3.43
NS 
Peak HR (bpm) 147 ± 18 154 ± 15 +7NS 
Peak PO (W) 108 ± 36 131 ± 45 +23NS 
Peak RER 1.11 ± 0.10 1.15 ± 0.07 +0.04NS 
Peak SBP (mmHg) 175 ± 26 177 ± 21 +2NS 
Kobashigawa et 
al. (1999) 
Maximal exercise 
test/ bicycle 
ergometer 
V O2peak (ml/kg/min) 9.2 13.6 +4.4
NS (+49%)PC 
Peak HR (bpm) 102 125 +23NS (+23%)PC 
Peak workload (W) 59 94 +35NS (+59%)PC 
Resting HR (bpm) 90 100 +10NS (+11%)PC 
Resting SBP (mmHg) 126 121 -5NS (-4%)PC 
Peak SBP (mmHg) 141 148 +7NS (+5%)PC 
V E (l/min) 38 45 +7
NS (+18%)PC 
Rustad, Nytrøen, 
Amundsen, 
Gullestad, & 
Aakhus (2014) 
Maximal exercise 
test/ treadmill 
V O2peak (ml/kg/min) 27.7 ± 5.5 30.9 ± 5.3 +3.2
*  
Peak HR (bpm) 159 ± 14 163 ± 13 +4**  
Peak RER 1.07 ± 0.06 1.08 ± 0.04 +0.01*** 
Wu et al. (2008) Maximal exercise 
test/ bicycle 
ergometer 
V O2peak (ml/kg/min) 12.1 ± 2.7 13.2 ± 3.9 +1.0
NS 
Peak HR (bpm) 120.6 ± 15.8 121.6 ± 16.7 +1.1NS 
Peak workload (W) 55.1 ± 17.3 64.9 ± 19.3 +9.7NS 
Resting HR (bpm) 96.3 ± 8.7 95.2 ± 6.8 -1.1NS 
Resting SBP (mmHg) 129.3 ± 16.4 130.6 ± 14.9 +1.3NS 
V E (l/min) 41.9 ± 9.5 44.6 ± 10.6 +2.7
NS 
Haykowsky et al. 
(2005) 
Maximal exercise 
test/ bicycle 
ergometer 
V O2peak (ml/kg/min) 14 20 +6
** 
Peak HR (bpm) 109 ± 14 134 ± 15 +25** 
Peak PO (W) 79 ± 21 113 ± 31 +34** 
Values are reported as mean/ mean ± SD; NS not stated P value; PC percentage change; * P ≤ .001; ** P < .05; *** P > 
.05. HR, heart rate; PO, power output; RER, respiratory exchange ratio; SBP, systolic blood pressure; V E, minute 
ventilation 
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As for the comparison between the training and the control groups (see Table 9), most 
RCTs reported a significantly higher VO2peak in the training group. The mean increase 
ranged from +2.5 to +3.7 ml/kg/min. However, one study reported no significant 
changes of VO2peak between both groups (Wu et al., 2008). Two RCTs reported that 
peak workload was significantly higher in the training group, accounting for +23 W in 
Kobashigawa et al. (1999) and +10.7 W in Wu et al. (2008) compared to the controls. 
Additionally, one study reported significantly higher peak PO (+20.9 W) in the training 
group (Haykowsky et al., 2009). 
Regarding the change of peak HR in RCTs, the significantly greater value in the training 
group was reported in one study (Rustad et al., 2014), while the other three RCTs 
reported no significant changes compared to the controls. 
Furthermore, for the other variables, including peak RER, resting HR, SBP, V E, no 
significant differences were reported between the training and control groups. 
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Table 9 Summary results of exercise test: Comparison between the training and control groups in the 
included randomised controlled trials 
Study Parameter Control Training Difference 
between 
group 
Baseline Post-
training 
Mean 
change 
Mean 
change 
Haykowsky, 
Taylor, Kim, & 
Tymchak (2009)$ 
VO2peak (ml/kg/min) 18.2 ± 5.9 18.2 ± 5.3 0.04 +3.43 3.11
** 
Peak HR (bpm) 139.1 ± 19 139.0 ± 20 -0.05 +7.0 6.73*** 
Peak PO (W) 106 ± 27 107 ± 30 +0.8 +23 20.9* 
Peak RER 1.09 ± 0.08 1.10 ± 0.1 +0.01 +0.04 0.04*** 
Peak SBP (mmHg) 172 ± 29 180 ± 27 +8 +2 9.5*** 
Kobashigawa et 
al. (1999) 
VO2peak (ml/kg/min) 10.4  12.3 +1.9 +4.4 2.5
** 
Peak HR (bpm) 107  134 +27 +23 4*** 
Peak workload (W) 66  78 +12 +35 23** 
Resting HR (bpm) 91  109 +18 +10 8*** 
Resting SBP (mmHg) 130  114 -16 -5 11*** 
Peak SBP (mmHg) 139  148 +9 +7 2*** 
V E (l/min) 46  62 +16 +7 9
*** 
Rustad, Nytrøen, 
Amundsen, 
Gullestad, & 
Aakhus (2014) 
VO2peak (ml/kg/min) 28.5 ± 7.0 28.0 ± 6.7 -0.5 +3.2  3.7
* 
Peak HR (bpm) 154 ± 15 154 ± 17 0 +4 4** 
Peak RER 1.06 ± 0.05 1.07 ± 0.05 +0.01 +0.01 0*** 
Wu et al. (2008) VO2peak (ml/kg/min) 13.7 ± 3.3 13.2 ± 3.7 -0.5 +1.0
 1.6*** 
Peak HR (bpm) 132.7 ± 15.7 130.8 ± 14.1 -2.0 +1.1 3.1*** 
Peak workload (W) 73.5 ± 23.4 72.6 ± 20.9 -1.0 +9.7 10.7** 
Resting HR (bpm) 97.0 ± 7.0 96.0 ± 6.7 -1.1 -1.1 0*** 
Resting SBP (mmHg) 121.9 ± 14.6 122.1 ± 13.0 +0.2 +1.3 1.1*** 
V E (l/min) 45.4 ± 10.9 45.2 ± 10.9 +0.3 +2.7
 2.4*** 
Values are reported as mean/ mean ± SD; $ difference values between groups after adjusted analysis; * P < .001; ** P 
< .05; *** P > .05. HR, heart rate; PO, power output; RER, respiratory exchange ratio; SBP, systolic blood pressure; 
V E, minute ventilation  
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5.4 Effects on muscle performance 
According to Table 10, three RCTs showed that the improvement of lower extremity 
muscular strength in the training group was significantly greater than that in the 
control group for the sit-to-stand rate in 1 minute (Kobashigawa et al., 1999; Wu et al., 
2008) and leg-press strength (Haykowsky et al., 2009). Although Wu et al. (2008) 
reported a significant improvement in muscle fatigue index, there was no significant 
difference in isometric maximal strength of quadriceps using an isokinetic 
dynamometer. One trial reported that chest-press strength was significantly higher in 
the training group when compared with the controls but no significant improvements 
in other muscle groups of the upper limbs were reported (Haykowsky et al., 2009). 
Additionally, a significant effect of ET on increased leg and total lean tissue mass (LTM) 
was also reported in the study of Haykowsky et al. (2009). 
5.5 Effects on cardiovascular function 
In Table 10, submaximal cycle exercise echocardiographic test was conducted to assess 
cardiovascular function of HTRs in both UCT and RCTs (Haykowsky et al., 2005; 
Haykowsky et al., 2009; Rustad et al., 2014). These studies did not show any significant 
improvement in cardiovascular function, including LV systolic function, stroke volume 
(SV) and cardiac output [ Q ], in HTRs after the training period. Moreover, one study 
reported that there were no significantly changes in brachial artery endothelial 
function (EnF) in the training group compared with controls (Haykowsky et al., 2009). 
5.6 Adverse events 
No adverse events related to ET were reported in the included studies (see Table 10). 
53 
 
Table 10 Summary of outcomes regarding muscle performance, cardiovascular function and adverse 
event 
Study Test method Outcome 
1. Muscle performance 
Haykowsky, Taylor, 
Kim, & Tymchak 
(2009)RCT 
1-RM test 
 
 Leg-press (34.7 kg, 95% CI 3.7-65.6)* 
 Chest-press (10.4 kg, 95% CI 5.2-15.5)* 
 Latissimus dorsi pulldown and arm curl** 
Dual energy x-ray absorptiometry  Leg LTM (0.78 kg, 95% CI 0.31-1.3)* 
 Total LTM (1.34 kg, 95% CI 0.34-2.3)* 
Kobashigawa et al. 
(1999)RCT 
Sit-to-stand within 1 minute 
 
 Sit-to-stand rate (+13.3 no./min)* 
Wu et al. (2008)RCT Isokinetic dynamometer 
 
 Fatigue index (+8.8 ± 10.5%)* 
 Isometric maximal strength of quadriceps** 
Sit-to-stand within 1 minute  Sit-to-stand rate (+5.1 ± 3.6 no./min)* 
2. Cardiovascular function 
Haykowsky, Taylor, 
Kim, & Tymchak 
(2009)RCT 
Submaximal cycle exercise 
echocardiographic test 
 EDA, ESA, stroke area and area EF at rest and 
submaximal exercise** 
Brachial artery ultrasound imaging  Brachial artery EDVD and EIVD** 
Rustad, Nytrøen, 
Amundsen, Gullestad, 
& Aakhus (2014)RCT 
Submaximal cycle exercise 
echocardiographic test 
 All parameters, including EF, EDV, ESV and Q ** 
Haykowsky et al. 
(2005)UCT 
Submaximal cycle exercise 
echocardiographic test 
(1) During exercise: 
-  EDV, ESV and Q ** 
-  The effective arterial elastance* 
-  SV and EF* 
(2) At rest:  
 All parameters 
3.  Adverse event 
Yes - 
No Haykowsky, Taylor, Kim, & Tymchak (2009); Kobashigawa et al. (1999); Rustad, Nytrøen, 
Amundsen, Gullestad, & Aakhus (2014); Wu et al. (2008); Haykowsky et al. (2005) 
RCT Compare training with control; UCT Compare post-training with baseline; , increase; , decrease; , no change; * 
P < .05; ** P > .05. RM, repetition maximum; EDA, end-diastolic cavity area; EDV, end-diastolic volume; EDVD, 
endothelial-dependent vasodilation; EF, ejection fraction; EIVD, endothelial-independent vasodilation; ESA, end-
systolic cavity area; ESV, end-systolic volume; LTM, lean tissue mass; Q , cardiac output; SV, stroke volume 
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6. Discussion 
6.1 Findings 
The effect of exercise-based CR on improving exercise capacity in adult HTRs has been 
reported by the latest Cochrane reviews (Anderson et al., 2017) but the median age of 
patients within trials (54.4 years) was not representative of the elderly HTRs, which are 
growing over time. By only including studies whose training participants were older 
than 55 years of age, studies in the current review demonstrated significant increased 
exercise capacity in elderly HTRs after undergoing exercise-based CR despite no 
significant improvement of cardiovascular function. 
HTRs who were ≥55 years of age have been defined as elderly patients (Borkon et al., 
1999; Tjang et al., 2008); therefore, study participants in this review, which had a 
median age of 57 years, can be defined as elderly HTRs. This median age of training 
participants is also more than that for adult transplants in the ISHLT Registry, i.e. 55 
years (Lund et al., 2017). However, it should be noted that there were two studies that 
had an average age of control participants of <55 years (Kobashigawa et al., 1999; Wu 
et al., 2008). 
After surgery, decreased exercise capacity in HTRs can result from either central (e.g. 
reduced Q , chronotropic incompetence, pulmonary dysfunction, and systolic and 
diastolic dysfunction) or peripheral (e.g. reduced oxidative capacity, endothelial 
dysfunction, and reduced muscle mass and strength) factors (Nytrøen & Gullestad, 
2013). In addition to increased VO2peak after the training period, this current review 
also found a significant improvement in peak workload and peak PO, which can 
indicate that ET improved exercise capacity in elderly HTRs. Also, increased peripheral 
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muscular strength, and leg and total LTM without any significant improvement in 
cardiopulmonary function, including exercise LV systolic function, Q  and V E were 
reported in some studies. Additionally, decreased SV and ejection fraction (EF) after 
training were also found in one UCT (Haykowsky et al., 2005). 
Haykowsky et al. (2009) stated that skeletal muscle adaptations (i.e. improved skeletal 
morphology and oxidative enzyme activity) may lead to oxygen utilization 
improvement and this can result in increased exercise capacity. In this way, an increase 
in exercise capacity in elderly HTRs may be mainly related to such peripheral 
adaptations after ET. However, a significant increase in chest press strength without 
any improvements in latissimus dorsi pulldown and arm curl strength was insufficient 
evidence to determine the effects of exercise training on upper extremity muscular 
strength in elderly HTRs. A period of approximately 4-5 years posttransplant of 
participants in Haykowsky et al. (2009) may cause no significant changes in such 
muscle groups between the training and control groups due to a recovery after 
surgery. 
Although no significant improved resting HR and peak HR was reported in most RCTs in 
this review, significant improved peak HR in the training subjects was reported in one 
study, which used a 1-year programme of HIIT (Rustad et al., 2014). Nytrøen et al. 
(2012) demonstrated that a 1-year HIIT-programme decreased resting HR, increased 
peak HR and increased HR reserve in HTRs compared to the controls. However, the use 
of a 4-week combination programme of moderate CT and HIIT in Haykowsky et al. 
(2009) did not result in significant change in peak HR. This means that the ≥1-year HIIT-
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programme may be more effective to alleviate chronotropic incompetence in elderly 
HTRs. 
Due to chronotropic incompetence, HR-based intensity is not appropriate for HTRs, 
whereas RPE is recommended (American Association of Cardiovascular and Pulmonary 
Rehabilitation [AACVPR], 2013; American College of Sports Medicine [ACSM], 2018; 
Association of Chartered Physiotherapists in Cardiac Rehabilitation [ACPICR], 2015). 
Moreover, 10-15 minutes of warm-up and cool-down were also important (ACPICR, 
2015). In this review, training intensity of aerobic exercise was mostly based on 
percentages of VO2peak and RPE, while Rustad et al. (2014) used percentages of peak 
HR. The use of warm-up and cool-down was stated in only two studies. One reported 5 
minutes of warm-up and cool-down (Wu et al., 2008) and one reported only 10 
minutes of warm-up (Rustad et al., 2014). These inappropriate prescriptions might 
affect the validity of data outcomes. 
With the exception of Rustad et al. (2014), all the studies in this review included 
strength training, which can counteract the adverse side effects of 
immunosuppressants on bone and skeletal muscle as stated in AACVPR (2013) and 
ACSM (2018). 
A cycle ergometer was used as a testing device in the majority of studies, while one 
study used a treadmill for exercise testing (Rustad et al., 2014). Treadmill testing is 
claimed to be more suitable for subjects because people are familiar with walking 
(Foster, Hume, Dickinson, Chatfield, & Byrnes, 1986) and results in 11% higher maximal 
oxygen consumption ( VO2max) than during cycling (Huggett, Connelly, & Overend, 
2005). However, the use of a cycle ergometer may be more appropriate for older 
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adults because it is suitable for common elderly health problems, including balance 
deficit, as well as being easier to obtain physiological measures during exercise testing 
(Huggett et al., 2005). These differences of between exercise testing methods should 
be taken into consideration. 
An increase in exercise capacity by 1 metabolic equivalent (MET) was associated with 
12% increased survival in CVD patients (Myers et al., 2002). In this review, the mean 
increase in VO2peak after the training period ranged from 2.5-3.7 ml/kg/min as 
compared to the baseline in all studies and ranged from 3.2-6.0 ml/kg/min as 
compared to the controls within RCTs. Based on the standard MET (i.e. 1 MET = 3.5 
ml/kg/min), this means that ET may lead to reduced risk of death in elderly HTRs. 
It has been stated that cyclosporin, which is a commonly used immunosuppressant 
therapy, is associated with arterial hypertension, vasodilation impairment and 
endothelial cell damage (Miller, 2002). For this reason, no significant improvement of 
EnF, which was found in this review, may result from cyclosporin toxicity. However, 
Schmidt et al. (2002) revealed that improved flow-mediated vasodilation in elderly 
HTRs participating in aerobic training indicated that a regular exercise programme may 
overcome the adverse side effects of cyclosporin on vascular impairment. Due to the 
small size of the study by Schmidt et al. (2002) (i.e. 7 for training HTRs; 6 for sedentary 
HTRs; 6 for healthy controls) and the fact that in this current review only one trial 
assessed brachial artery EnF, there was inadequate evidence to determine the effect of 
exercise on EnF in elderly HTRs. 
In 2017, a Cochrane review of 23 RCTs showed that the effect of home-based CR on 
exercise capacity was similar to that of centre-based CR for both short- and long-term 
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programmes (Anderson et al., 2017). In this review, while three RCTs, which were a 
centre-based programme, reported increased VO2peak when compared to the 
controls, no significant value was reported in an RCT with a home-based programme 
(Wu et al., 2008). However, this inconsistent result cannot be considered conclusive 
due to a very small number of included studies that used home-based exercise in this 
review (i.e. one study). 
As for adverse events, although none of the included studies reported any adverse 
events related to the exercise programme, it should be noted that included subjects in 
all studies were clinically stable HTRs. 
6.2 Limitations 
There are a number of limitations in this review. Firstly, the small number of trials due 
to the limited study of elderly HTRs makes it difficult to draw definitive conclusions. 
Secondly, the studies were conducted over a short period (i.e. a median of 12 weeks 
[range 8-48]). Therefore, there was no evidence to assess the long-term effect of 
exercise-based CR. In terms of risk of bias in the included studies, this review included 
one UCT (Haykowsky et al., 2005), which was rated 3 out of 10 of a PEDro score. 
Although subjects in all RCTs were randomly assigned to the groups, these subjects 
and the staff supervising the ET were not blinded. Despite receiving a PEDro score of 5 
out of 10, the study of Wu et al. (2008) was considered high risk of bias because four 
participants that were randomly assigned to the training group chose to participate in 
the control group. Additionally, this review included two trials that were from the 
same centre with the same lead author (Haykowsky et al., 2005; Haykowsky et al., 
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2009). Finally, this current review was conducted by a single reviewer due to it being a 
Master’s dissertation. This may have caused selection bias and a number of errors. 
6.3 Further studies 
Although the findings of this review have shown that exercise-based CR increases 
exercise capacity in elderly HTRs, this is a short-term effect of ET. Future studies should 
be designed to assess long-term sustainability of exercise-based CR on exercise 
capacity by focusing on a longer follow-up period (i.e. >1 year). 
7. Conclusion 
Despite there being no significant alterations of cardiovascular function, exercise-
based CR can improve exercise capacity in elderly HTRs through an improvement of 
peripheral skeletal muscle performance. Aerobic and strength training are safe for 
elderly HTRs who are clinically stable. Additionally, there is a possible beneficial effect 
of ≥1-year HIIT on improving peak HR in elderly HTRs. The different effects of home‐ 
versus centre‐based ET are uncertain due to the small number of trials. Other 
outcomes, including endothelial function, cannot be conclusive due to the small size of 
included trials. However, this review has indicated that prospective controlled trials on 
exercise-based CR in elderly HTRs are limited, therefore further research is needed. 
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9. Appendices 
Appendix A: Search terms and key words 
Terms for 
heart transplantation 
Terms for 
exercise-based 
cardiac rehabilitation 
Terms for 
exercise capacity 
Heart transplant* 
Cardiac transplant* 
 
Cardiac rehabilitation 
Rehabilitation 
Exercise 
Exercise intervention 
Exercise program 
Exercise programme 
Exercise training 
Physiotherapy 
Physical therapy 
Physical activity 
Training* 
Aerobic* 
Strength* 
Exercise capacity 
Exercise performance 
Physical function 
Oxygen consumption 
VO2 
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Appendix B: PEDro scale and brief explanation of each item 
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Appendix C: Excluded studies 
Study Reason for exclusion 
1. Bernardi, L., Radaelli, A., Passino, C., Falcone, C., Auguadro, C., Martinelli, L., . . . Finardi, G. (2007). Effects of 
physical training on cardiovascular control after heart transplantation. International Journal of Cardiology, 118(3), 
356-362. https://dx.doi.org/10.1016/j.ijcard.2006.07.032 
Mean age of participants < 55 years 
(Mean age ± SD: training = 50 ± 3 years; 
control = 53 ± 4 years) 
2. Braith, R. W., Schofield, R. S., Hill, J. A., Casey, D. P., & Pierce, G. L. (2008). Exercise training attenuates 
progressive decline in brachial artery reactivity in heart transplant recipients. Journal of Heart and Lung 
Transplantation, 27(1), 52-59. https://dx.doi.org/10.1016/j.healun.2007.09.032 
Mean age of participants < 55 years 
(Mean age ± SD: training = 54.4 ± 13.1 
years; control = 54.3 ± 9.5 years) 
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Mean age of participants < 55 years 
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years; control = 47.3 ± 17.9 years) 
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Full paper was not found 
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Unable to access the full paper 
 
72 
 
Study Reason for exclusion 
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7. Kawauchi, T. S., de Almeida, P. O., Lucy, K. R., Bocchi, E. A., Feltrim, M. I. Z., & Nozawa, E. (2013). Randomized 
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https://dx.doi.org/10.1093/eurheartj/eht310.P5780 
Full paper was not found 
17. Tegtbur, U., Busse, M. W., Jung, K., Markofsky, A., Machold, H., Brinkmeier, U., . . . Pethig, K. (2003). Phase III 
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Appendix D: Validity of included studies 
 
Criteria (the PEDro scale) 
Haykowsky, Taylor, 
Kim, & Tymchak (2009) 
Kobashigawa et al. 
(1999) 
Rustad, Nytrøen, 
Amundsen, Gullestad, 
& Aakhus (2014) 
Wu et al. (2008) Haykowsky et al. 
(2005) 
1. Eligibility criteria were specified No No No Yes No 
2. Subjects were randomly allocated to groups (in 
a crossover study, subjects were randomly 
allocated an order in which treatments were 
received) 
 
 
1 
 
 
1 
 
 
1 
 
 
1 
 
 
0 
3. Allocation was concealed 0 1 1 0 0 
4. The groups were similar at baseline regarding 
the most important prognostic indicators 
 
0 
 
1 
 
1 
 
1 
 
0 
5. There was blinding of all subjects 0 0 0 0 0 
6. There was blinding of all therapists who 
administered the therapy 
 
0 
 
0 
 
0 
 
0 
 
0 
7. There was blinding of all assessors who 
measured at least one key outcome 
 
0 
 
0 
 
1 
 
0 
 
0 
8. Measures of at least one key outcome were 
obtained from more than 85% of the subjects 
initially allocated to groups 
 
1 
 
1 
 
1 
 
0 
 
1 
9. All subjects for whom outcome measures were 
available received the treatment or control 
condition as allocated or, where this was not 
the case, data for at least one key outcome was 
analysed by “intention to treat” 
 
 
 
0 
 
 
 
0 
 
 
 
0 
 
 
 
1 
 
 
 
0 
10. The results of between-group statistical 
comparisons are reported for at least one key 
outcome 
 
1 
 
1 
 
1 
 
1 
 
1 
11. The study provides both point measures and 
measures of variability for at least one key 
outcome 
 
1 
 
0 
 
1 
 
1 
 
1 
Total score (maximum = 10) 4 5 7 5 3 
 
76 
 
Appendix E: Characteristics of included studies 
Author: Haykowsky, Taylor, Kim and Tymchak (2009) 
Title: Exercise training improves aerobic capacity and skeletal muscle function in heart 
transplant recipients 
Study design Randomised controlled trial 
Validity score  PEDro scale = 4/10 
Location/ Funding Canada/ Heart and Stroke Foundation of Alberta, NWT & Nunavut 
Study objectives To examine the effects of 12-week supervised aerobic and strength training 
(SET) vs. no-training (NT) on aerobic capacity, submaximal exercise LV systolic 
function, peripheral vascular function, lean tissue mass (LTM) and maximal 
muscular strength in clinically stable HTRs 
Participants Inclusion criteria: Clinically stable HTRs after HTx ≥ 0.5 years 
Exclusion criteria: Not stated 
Number of randomised participants: 43 (training: 22; control: 21) 
Age (mean ± SD): Training: 57 ± 10 years; control: 59 ± 11 years 
Time since HTx: Training: 5.4 ± 4.9 years; control: 4.4 ± 3.3 years 
Drop out/ reason 
- Training: 1 (4.5%)/ 1 subject had significant coronary disease 
- Control: 2 (9.5%)/ 2 subjects requested not to perform the post-intervention 
assessments 
Notes: There was a statistically significant difference between both groups in the 
following baseline characteristics: 
- Pre-transplant ischemic heart failure (training: 45%; control: 76%, P = .04) 
- Body weight (training: 80 ± 22 kg; control: 93 ± 14 kg, P = .03) 
Interventions Setting: Centre-based exercise programme 
Components: Exercise only 
Interventions: Supervised aerobic and strength training 
Total duration: 12 weeks 
Aerobic training Training method: Treadmill and cycle exercise 
Frequency:  
- First 8 weeks: 5 days/week 
- Final 4 weeks: 3 days/week for continuous training; 2 days/week for interval 
training 
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Haykowsky, Taylor, Kim and Tymchak (2009): Continued 
 Intensity:  
- First 8 weeks: 60-80% VO2peak 
- Final 4 weeks: 80% VO2peak for continuous training; 90-100% of baseline peak 
power output (PO) for interval training (cycle) 
Time per session:  
- First 8 weeks: 30-45 minutes 
- Final 4 weeks: 45 minutes for continuous training; 15-37.5 minutes for interval 
training (30s exercise followed by 60s rest x initially 10 repetitions and gradually 
increase to 25 repetitions) 
Strength training Training method: Chest press, latissimus dorsi pull down and arm curls for upper 
extremities; leg press for lower extremities 
Frequency: 2 days/week 
Intensity: 50% of maximal strength 
Time per session: 1-2 sets of 10-15 repetitions 
Control group - No training and exercise guidelines 
- Continue usual activities of daily living 
Co-interventions Medication such as ASA, beta blocker, azathioprine, cyclosporine and prednisone 
(same medication within the groups) 
Outcomes 1. Aerobic capacity 
Exercise testing method: Electrically braked cycle ergometer 
Exercise testing protocol: Incremental cycle exercise test to the VO2peak 
(initially set PO 15 W and increase by 15 W every 2 minutes) 
2. LV systolic function 
Method: Two-dimensional transthoracic echocardiography at rest and 
submaximal (25%, 50% and 75% of baseline peak PO) cycle exercise. 
3. Brachial artery endothelial function 
Method: Brachial artery ultrasound imaging 
4. Maximal muscular strength 
Method: 1-RM test (leg press; chest press; latissimus dorsi pulldown; right and 
left arm curls) 
5. Lean tissue mass 
Method: Imaging technique (dual energy x-ray absorptiometry) 
Adverse outcomes No adverse events 
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Haykowsky, Taylor, Kim and Tymchak (2009): Continued 
Results with statistical 
significance 
1. Aerobic capacity 
1.1 VO2peak (+3.11 ml/kg/min [95% CI 1.19-5.03], P = .003) and peak PO (+20.9 
W [95% CI 11.96-29.9], P < .0001) of SET were significantly higher than that of NT 
(adjusted analysis) 
1.2 No significant difference of changes in peak RER (0.04 [95% CI -0.02-0.10], P 
= .17), peak HR (6.73 bpm [95% CI -0.05-13.5], P = .06), SBP (-9.5 mmHg [95% CI -
22.6-3.64], P = .17) and DBP (2.6 mmHg [95% CI -4.1-9.3], P = .46) between SET 
and NT (adjusted analysis) 
2. LV systolic function 
End-diastolic cavity area, end-systolic cavity area, stroke area and area ejection 
fraction at rest and submaximal (25%, 50%, 75%) cycle exercise were not 
significantly different in both SET and NT after training (P > .05) 
3. Brachial artery endothelial function 
Endothelial-dependent and -independent vasodilation were not significantly 
different in both SET and NT (P > .05) 
4. Maximal muscular strength 
Leg-press (34.7 kg, 95% CI 3.7-65.6) and chest-press strength (10.4 kg, 95% CI 
5.2-15.5) were significantly higher (P < .05) in SET vs. NT with no difference in 
latissimus dorsi pulldown or arm curl strength (P > .05). 
5. Lean tissue mass 
Leg (0.78 kg, 95% CI 0.31-1.3) and total LTM (1.34 kg, 95% CI 0.34-2.3) were 
significantly higher in SET compared to NT (P < .05) 
Conclusion Supervised aerobic and strength training for 12 weeks results in an increase in 
VO2peak, leg and total LTM as well as upper and lower extremity maximal 
strength in clinically stable HTRs without improving exercise LV systolic function 
or brachial artery endothelial function. 
Key discussion points The effects of 12 weeks of supervised aerobic and strength do not improve 
cardiovascular function in HTRs but can improve aerobic capacity through 
peripheral skeletal muscle adaptations, which result in increased oxygen 
utilization by the active muscles. 
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Author: Kobashigawa et al. (1999) 
Title: A controlled trial of exercise rehabilitation after heart transplantation 
Study design Randomised controlled trial 
Validity score  PEDro scale = 5/10 
Location/ Funding USA/ not stated 
Study objectives To assess the effect of 6-month programme of rehabilitative exercise on 
physical-work capacity and activities of daily living in HTRs 
Participants 
 
Inclusion criteria: HTRs who underwent the midatrial-cuff technique between 
August 1992 and June 1993 
Exclusion criteria: Multiple medical limitations due to prolonged hospitalisation 
Number of randomised participants: 27 (training: 14; control: 13) 
Age (mean ± SD): Training: 55 ± 8 years; control: 50 ± 12 years 
Time since HTx: 2 weeks (both groups) 
Drop out: Not stated 
Notes: There were no statistically significant differences of baseline 
characteristics between groups, including the mean dose of prednisone, the 
number of rejection episodes and the number of infections. 
Interventions Setting: Centre-based exercise programme and some specific instructions for 
exercising at home 
Components: Exercise only 
Interventions: Supervised aerobic, strengthening and flexibility exercises 
Total duration: 6 months 
Notes: 
- Subjects in the training group received an individual supervised programme of 
exercise by physiotherapists according to their physical examination results 
- Subjects in both groups received written guidelines to be performed at home 
included: shoulder circles (10 times forward and 10 times backward); shoulder 
retraction (10 repetitions); side bends (10 times in each direction); half-squats 
(10-20 repetitions); toe raises (10-20 repetitions). 
- Subjects in both groups received written walking guidelines to be performed at 
home:  
   1st week, comfortable pace walking 5-10 minutes, 3-4 times/day  
   2nd week, comfortable pace walking 10-15 minutes, 3 times/day 
   3rd week, comfortable pace walking 15-20 minutes, 2 times/day  
   4th week, comfortable pace walking 20-30 minutes, 1 time/day  
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Kobashigawa et al. (1999): Continued 
 5th week, comfortable pace walking 30-40 minutes, 1 time/day 6th week, 
walking 30-40 minutes with increasing the pace, every day 
Aerobic training Training method: Treadmill, bicycle or arm ergometer 
Frequency: Initially, centre-based exercise programme: 1-3 times/ week. Then, 
gradually reduced to 1 time/ 2 weeks (to encourage independent exercise at 
home) 
Intensity: Moderate intensity due to patient’s tolerance 
Time per session: ≥ 30 minutes of continuous exercise 
Notes: Duration and intensity were increased to meet the individual’s tolerance 
Strength training Training method: Closed-chain resistive activities (such as bridging, half-squats, 
and toe raises) and abdominal exercise 
Frequency: Similar to aerobic training  
Intensity: Not stated 
Time per session: Not stated 
Flexibility training Training method: Chest expansion and thoracic mobility exercises (side 
stretches, trunk twists, scapula squeezes and shoulder rolls) 
Frequency: Similar to aerobic training 
Intensity: Not stated 
Time per session: Not stated 
Control group Undergo unstructured exercise (receiving written exercise guidelines and 
participating in non-formal supervised exercise sessions after discharge from the 
hospital) 
Co-interventions - Triple-drug immunosuppression (cyclosporine, azathioprine, and prednisone) 
- Written exercise guidelines at home 
Outcomes 1. Aerobic capacity 
Exercise testing method: Bicycle ergometry 
Exercise testing protocol: Incremental symptom-limited (initially set no 
workload for 3 minutes and increase by 10 W every 1 minute [keep pedalling at 
50-70 rpm] until the point of VO2peak) 
2. Muscle strength 
Method: Sit-to-stand within 1 minute 
Adverse outcomes No adverse events 
Results with statistical 
significance 
1. Aerobic capacity 
The training group had significantly greater improvements in following 
cardiopulmonary function than that in the control group. 
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Kobashigawa et al. (1999): Continued 
Results with statistical 
significance 
- VO2peak (ml/kg/min): training vs. control: +4.4 vs. +1.9, P = .01 
- Workload (W): training vs. control: +35 vs. +12, P = .01 
- Ventilatory equivalent for carbon dioxide: training vs. control: -13 vs. -6, P = .02 
No significant difference of changes between the training and control groups in 
ventilatory equivalent for oxygen (-12 vs. -4, P = .09), duration of exercise (+2.1 
vs. +1.1 min, P = .07), time to estimated lactic acidosis threshold (+1.5 vs. 0 min, 
P = .09), resting HR (+10 vs. +18 bpm, P = .06), peak HR (+23 vs. +27 bpm, P = 
.25), resting SBP (-5 vs. -16 mmHg, P = .20), peak SBP (+7 vs. +9 mmHg, P = .46) 
and minute ventilation (+7 vs. +16 L/min, P = .10) 
2. Muscle strength 
The increase in the sit-to-stand rate (no./min) was significantly greater in the 
training group than in the control group (+13.3 vs. +5.6, P = .02) 
Conclusion Early provision of a structured, individualised exercise programme improves 
physical work capacity in HTRs. 
Key discussion points The improvement in the lactic acidosis threshold after exercise training in this 
study indicates that increased physical capacity in HTRs relates to a physiologic 
training effect rather than the ability to perform at a greater level of exertion. 
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Author: Rustad, Nytrøen, Amundsen, Gullestad and Aakhus (2014) 
Title: One year of high-intensity interval training improves exercise capacity, but not 
left ventricular function in stable heart transplant recipients: A randomised controlled 
trial 
Study design Randomised controlled trial 
Validity score  PEDro scale = 7/10 
Location/ Funding Norway/ the Norwegian University of Science and Technology and the South-
East Health Region in Norway 
Study objectives To investigate the effects of 1-year HIIT on cardiac function and exercise capacity 
in stable HTRs by using comprehensive rest- and exercise-echocardiography and 
cardiopulmonary exercise testing 
Participants Inclusion criteria:  
- Clinically stable HTRs after HTx 1-8 years with optimal medical treatment 
- Ability to perform maximal exercise testing 
- Willingness to fulfil 1-year exercise training 
Exclusion criteria: HF, signs of rejection, atrial fibrillation, need for 
revascularisation or other intervention 
Number of randomised participants: 52 (training: 26; control: 26) 
Age (median [range]): Training: 56 years (20-72); control: 58 years (19-71) 
Time since HTx: Training: 5 years (1-8); control: 4 years (1-7) 
Drop out/ reason 
- Training: 2 (7.7%)/ 1 subject had cholecystitis; 1 subject had depression 
- Control: 2 (7.7%)/ 1 subject had myocardial infarction; 1 subject missed 
baseline VO2peak test 
Notes:  
- The training group had significant lower estimated glomerular filtration rate 
(eGFR) than that in the control group (P = .025) 
- Statistical analyses comprised 24 subjects in each group (drop out subjects 
were excluded) 
Interventions Setting: Centre-based exercise programme 
Components: Exercise only 
Interventions: Supervised aerobic training 
Total duration: 1 year 
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Rustad, Nytrøen, Amundsen, Gullestad and Aakhus (2014): Continued 
Interventions Notes: 
- The intervention was divided into three eight-week periods of exercise 
- Exercise training consisted of 10-minute warm-up and 4 x 4-minute of work 
with 3-minute of active pause (no stated cool-down period) 
- The last eight-week period was finished 1-2 weeks before follow-up. 
Aerobic training Training method: Treadmill (walking or running uphill) 
Frequency: 3 sessions/week 
Intensity:  
- Work period: 85-95% of peak HR 
- Active pause period: Borg scale 11–13 
Time per session: 28 minutes (4 x 4-minute intervals, separated by 3-minute 
active pauses) 
Strength training No training 
Control group Requested to continue routine exercise 
Co-interventions Medication such as cyclosporine, azathioprine, corticosteroids, statin and beta 
blocker (no statistically significant differences between groups) 
Outcomes 1. Exercise capacity 
Exercise testing method: Treadmill 
Exercise testing protocol: A modified treadmill walking test (maximal exercise 
test) until volitional fatigue (Borg score >18 and/or RER ≥1.05); after a warm up 
of 10 minutes, the inclination was increased by 2% every 2 minutes. 
2. Cardiac function 
Exercise testing method: Bicycle ergometry 
Exercise testing protocol: Submaximal cycle exercise echocardiographic test in 
the semi-supine position (begin with a workload of 25 W and increase by 25 W 
every 2 minutes with constant frequency of 50-65 rpm) 
Notes:  
- 29 subjects were included in the analyses of exercise echocardiography. Due to 
logistics and poor image quality, 44 subjects were performed at baseline; 39 
subjects were performed at follow up; finally, those who had angle-deviation 
>20° in the tissue doppler images or reduced image quality during exercise were 
excluded. 
Adverse outcomes No adverse events 
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Rustad, Nytrøen, Amundsen, Gullestad and Aakhus (2014): Continued 
Results with statistical 
significance 
1. Exercise capacity 
The HIIT had a significant change in VO2peak (P < .001) and peak HR (P = .016); 
no changes in RER (P = .336) when compared with the controls.  
Outcomes of the HIIT group: 
- VO2peak (ml/kg/min): 27.7 ± 5.5 (pre) vs. 30.9 ± 5.3 (post), P ≤ .001 
- Peak HR (bpm): 159 ± 14 (pre) vs. 163 ± 13 (post), P < .05 
- RER: 1.07 ± 0.06 (pre) vs. 1.08 ± 0.04 (post), P > .05 
Outcomes of the control group: 
- VO2peak (ml/kg/min): 28.5 ± 7.0 (pre) vs. 28.0 ± 6.7 (post), P > .05 
- Peak HR (bpm): 154 ± 15 (pre) vs. 154 ± 17 (post), P > .05 
- RER: 1.06 ± 0.05 (pre) vs. 1.07 ± 0.05 (post), P > .05 
2. Cardiac function 
Overall, there were no differences within or between groups (P > .05) 
Conclusion HIIT is feasible in HTRs which can improve exercise capacity despite no 
significant alterations of cardiac systolic and diastolic function. Extra-cardiac 
adaptations are associated with an increase in exercise capacity in this 
population. 
Key discussion points HIIT did not improve contractile function as well as LV filling and relaxation in 
stable HTRs due to different responses to aerobic exercise training between a 
transplanted heart and a non-transplanted heart. Cardiac and peripheral 
vascular limitations in HTRs include HR regulation by circulating catecholamines, 
impaired systolic cardiac function, impaired LV diastolic function and relaxation, 
the progressive increase of myocardial fibrosis and negative effects of 
immunosuppressive therapy, such as hypertension, dyslipidaemia, impaired 
endothelial function and muscle atrophy. 
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Author: Wu et al. (2008) 
Title: Efficacy of a home-based exercise program for orthotopic heart transplant 
recipients 
Study design Randomised controlled trial 
Validity score  PEDro scale = 5/10 
Location/ Funding Taiwan/ not stated 
Study objectives To evaluate the effects of 8 weeks of home-based exercise programme on 
aerobic capacity, muscular strength and endurance, and QOL in HTRs 
Participants 
 
 
Inclusion criteria:  
- Clinically stable HTRs after HTx > 1 year 
- Free from acute rejection (confirmed by endomyocardial biopsy) and allograft 
vasculopathy (confirmed by coronary angiography) in the recent 2 months 
- Free from infection or any other major illnesses that might interfere with the 
assessment or participation 
(Participants were confirmed medical clearance by the transplantation team of 
the National Taiwan University Hospital, Taiwan) 
Exclusion criteria: Not stated 
Number of randomised participants: 37 (training: 14; control: 23)  
Age (mean ± SD): Training: 60.6 ± 6.2 years; control: 51.6 ± 12.8 years 
Time since HTx: Training: 1.6 ± 1.8 years; control: 2.6 ± 1.9 years 
Drop out/ reason 
- Training: 2 (14.3%)/ 2 subjects lost to follow-up due to time restraints 
- Control: 4 (17.4%)/ 2 subjects had progressive renal dysfunction and anaemia; 
2 subjects dropped out due to personal reasons 
Notes: 
- Initially, subjects were randomly assigned 18 HTRs to the training group and 19 
HTRs to the control group; then, 4 subjects chose to change from the training to 
control group due to time restraints. 
- The training group was significantly older than the control group (P < .05) 
Interventions Setting: Home-based exercise programme 
Components: Exercise only 
Interventions: Prescribed aerobic and strength training 
Total duration: 8 weeks  
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Wu et al. (2008): Continued 
 Notes:  
- Prescribed home-based exercise programme consisted of 5-minute warm-up, 
upper and lower extremity strengthening exercises, 25-30 minutes of aerobic 
exercises and 5-minute cool-down  
- Subjects in the training group were asked to visit the physiotherapy 
department for checking their exercise programmes every 1-2 weeks 
Aerobic training Training method: Walking and stepping exercises 
Frequency: ≥ 3 times/week 
Intensity: RPE 12-14 that is equivalent to 60-70% VO2peak for walking 
Time per session:  
- 15-20 minutes for walking 
- 10 minutes for stepping 
Strength training Training method:  
- Upper extremities: arms curls, triceps extension in shoulder elevation, chest 
press and standing shoulder press 
- Lower extremities: half squats, toe raises, bridging exercise and bridging 
exercise with 1 straight leg rising  
Frequency: Similar to aerobic training 
Intensity: Not stated 
Time per session: Not stated 
Control group No training; keep usual activity lifestyle 
Co-interventions Immunosuppressive therapy included prednisolone, cyclosporine, azathioprine 
and FK506 (similar in both groups) 
Outcomes 1. Aerobic capacity 
Exercise testing method: Electrically braked bicycle ergometer 
Exercise testing protocol: Symptom-limited maximal to exhaustion (leg fatigue, 
general fatigue or dyspnoea; unable to keep pedalling at a 50-60 rpm), initially 
set at 0 W and increase by 10 W every minute 
2. Muscle strength and endurance 
Method:  
- Isokinetic dynamometer (Cybex 6000) to measure isometric and isotonic 
contraction of the right quadriceps 
- Sit-to-stand movements in 1 minutes 
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Wu et al. (2008): Continued 
 3. QOL 
Method: Using a brief version of the World Health Organization Questionnaire 
on Quality of Life (WHOQOL-BREF) 
4. PA and diet calories 
Method: A 7-day PA and a simple 24-hour unstructured diet recall questionnaire 
were used to evaluate daily PA and caloric intake of subjects, respectively, for 
every 4 weeks 
Adverse outcomes No abnormal haemodynamic responses; no major adverse events or mortality 
Results with statistical 
significance 
1. Aerobic capacity 
The training group had significantly higher difference in peak workload (W) than 
those in the control group (+9.7 ± 12.9 vs. -1.0 ± 7.6, P < .05) 
No significant changes (P > .05) between the training and the control groups: 
VO2peak (+1.0 ± 2.5 vs. -0.5 ± 1.8 ml/kg/min), peak HR (+1.1 ± 10.0 vs. -2.0 ± 8.7 
bpm), peak minute ventilation (+2.7 ± 10.8 vs. +0.3 ± 7.7 L/min), peak RPE (+0.4 
± 1.0 vs. +0.1 ± 0.8), resting HR (-1.1 ± 5.8 vs. -1.1 ± 3.5 bpm), resting SBP (+1.3 ± 
5.6 vs. +0.2 ± 9.2 mmHg) and resting DBP (-3.1 ± 7.8 vs. -1.0 ± 8.5 mmHg) 
2. Muscular strength and endurance 
2.1 Fatigue index (%): Fatigue index of the training group was significantly higher 
than that of the control group (+8.8 ± 10.5 vs. -2.5 ± 6.6, P < .05) 
2.2 Sit-to-stand rate (no./min): Sit-to-stand rate of the training group was 
significantly higher than that of the control group (+5.1 ± 3.6 vs. -0.4 ± 4.0, P < 
.05) 
3. QOL 
Significant difference between groups was found in the physical domain of QOL. 
The training group had higher scores than the control group (+0.61 ± 1.70 vs. -
0.55 ± 1.27, P < .05) 
4. PA and diet calories 
4.1 PA (kcal/day): a significant increase in PA was found in the training group 
when compared with the control group (+241.5 ± 159 vs. +44.1 ± 242, P < .05) 
4.2 Dietary intake (kcal/day): No significant changes (P > .05) between the 
training (-37 ± 354) and the control groups (+36 ± 304) during the study period 
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Wu et al. (2008): Continued 
 Notes: 
- Sit-to-stand rate was significantly correlated with isometric quadriceps 
strength measured by Cybex 6000 (r = 0.34, P < .05) 
- At baseline, the training group had lower sit-to-stand rate (21.1 ± 5.2 
no./min) than the control group (27.0 ± 5.5 no./min), P < .05 
- At post-test, despite no significant changes, an increasing trend was found in 
the training group 
Conclusion 8-week structured home-based exercise is safe and can improve lower 
extremity muscular strength and endurance, peak workload and QOL (physical 
domain) in HTRs. 
Key discussion points - Home-based training, which depends on self-efficacy, could cause the 
lack of significant change in VO2peak. 
- Improved physical performance and exercise tolerance after training affects 
the perception of HTRs, leading to improved QOL in physical domain. 
- An increase in daily energy consumption during the training period, 
according to the PA questionnaire, indicates lifestyle change which is 
importance for the long-term benefits in HTRs. 
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Author: Haykowsky et al. (2005) 
Title: Effect of exercise training on VO2peak and left ventricular systolic function in 
recent cardiac transplant recipients 
Study design Uncontrolled trial 
Validity score  PEDro scale = 3/10 
Location/ Funding Canada/ not stated 
Study objectives To examined the effect of 12 weeks of combined aerobic and resistance training 
on aerobic capacity, LVEF, and arterial afterload in HTRs 
Participants 
 
Inclusion criteria: Clinically stable HTRs after HTx < 1 month 
Exclusion criteria: Not stated 
Number of participants: 18 
Age (mean ± SD): 57 ± 6 years 
Time since HTx: < 1 month 
Drop out: Not stated 
Notes: The pre-transplant HF aetiology was ischemic cardiomyopathy (n = 11), 
idiopathic dilated cardiomyopathy (n = 4), hypertrophic cardiomyopathy (n = 1), 
sarcoidosis (n = 1), and valvular disease (n = 1) 
Interventions Setting: Centre-based exercise programme  
Components: Exercise only 
Interventions: Supervised aerobic and strengthening exercises 
Total duration: 12 weeks 
Aerobic training Training method: Treadmill and/or bicycle 
Frequency: 5 days/week 
Intensity: RPE 12-14 
Time per session: 30-40 minutes 
Strength training Training method: Lower extremity resistance training 
Frequency: Not stated  
Intensity: 50% of maximal strength, progressively increased as tolerated 
Time per session: 3-5 sets of 10 repetitions 
Control group - 
Co-interventions Medication (standard post-transplant pharmacologic therapy) 
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Haykowsky et al. (2005): Continued 
Outcomes 1. Aerobic capacity 
Exercise testing method: Bicycle ergometry 
Exercise testing protocol: Incremental cycle exercise test (initially set at 15 W 
and increased by 15 W every 2 minutes until the highest 1-minute oxygen 
consumption [ VO2peak]) 
2. Cardiac function 
Exercise testing method: Bicycle ergometry 
Exercise testing protocol: Submaximal cycle exercise echocardiographic test 
(50% of baseline peak PO) 
Adverse outcomes No adverse events 
Results with statistical 
significance 
1. Aerobic capacity 
After training, there was a significant increase in: 
1.1 VO2peak (ml/kg/min) 
- Pre- vs. post-training: approximately 14 vs. 20, P < .05 
1.2 Peak PO (W) 
- Pre- vs. post-training: 79 ± 21 vs. 113 ± 31, P < .05 
1.3 Peak HR (bpm) 
- Pre- vs. post-training: 109 ± 14 vs. 134 ± 15, P < .05 
2. Cardiac function 
After training, 
- The following values during submaximal exercise were significantly lower than 
pre-training 
2.1 SV (ml): 85 ± 22 (pre) vs. 78 ± 22 (post), P < .05 
2.2 EF (%): 78 ± 7 (pre) vs. 74 ± 7 (post), P < .05 
- The following values during submaximal exercise were significantly higher than 
pre-training 
2.3 The effective arterial elastance (mmHg/ml): 1.5 ± 0.5 (pre) vs. 1.7 ± 0.6 
(post), P < .05 
- The following values during submaximal exercise were not significant different 
2.4 EDV (ml): 108 ± 25 (pre) vs. 105 ± 28 (post), P > .05 
2.5 ESV (ml): 24 ± 9 (pre) vs. 27 ± 10 (post), P > .05 
2.6 Q  (L/min): 8.2 ± 1.9 (pre) vs. 7.9 ± 2.4 (post), P > .05 
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Haykowsky et al. (2005): Continued 
Conclusion 12 weeks of combined aerobic and resistance training leads to a significant 
increase in VO2peak in HTRs despite unfavourable improvements in LV systolic 
function due to a decrease in SV and EF after training 
Key discussion points The elevated arterial elastance in HTRs after training indicates that HTRs have 
increased arterial afterload, resulting in decreased exercise SV and EF. An 
increase in arterial afterload may be due to immunosuppression therapy, 
which is associated with an increase in peripheral vascular resistance; also, 
pre-transplant deconditioning or the detrimental effects of CHF on peripheral 
vascular function may result in increased arterial afterload. 
 
 
